feature_name,cui,cui_nomenclature,cui_def,KG_Hits,sim_score,feature_level_min_kg_hits,feature_level_sum_kg_hits,feature_level_avg_kg_hits,feature_importance,p_val,corr,MutualInfoTarget,raw_name,F.Split-Lift (y==1),F.Split-Support,F.Split-Feature Split,sim_score_target_feat,sim_score_target_cui,shortest_path_length
Urate,C0729829,Urate level - finding,Urate level - finding. ,0,0.759,0.0,0.0,0.0,0.8047,0.0,0.214,0.0667,Urate,4.68,1792,2.10 <= Urate < 2.90,0.18,0.29,2
Urate,C0935936,Urate,"Urate. 2,6,8-trioxypurine.",0,0.778,0.0,0.0,0.0,0.8047,0.0,0.214,0.0667,Urate,4.68,1792,2.10 <= Urate < 2.90,0.18,0.29,2
medication allopurinol,C0002144,allopurinol,allopurinol. A XANTHINE OXIDASE inhibitor that decreases URIC ACID production. It also acts as an antimetabolite on some simpler organisms.,0,0.884,0.0,0.0,0.0,0.3097,0.0,0.392,0.0414,Treatment/medication code | Array 0__allopurinol,6.97,3425,Treatment/medication code | Array 0__allopurinol >= 0.50,0.19,0.22,2
Number of self-reported non-cancer illnesses,C2700446,Self-Report,Self-Report. An individual's perspective or subjective interpretation of an event or information.,0,0.411,0.0,0.0,0.0,0.088,0.0,0.138,0.0101,Number of self-reported non-cancer illnesses,2.36,1149,Number of self-reported non-cancer illnesses >= 3.00,0.02,0.02,2
Home area population density - urban or rural Scotland - Large Urban Area,C0178587,density,density. The amount of something per unit size.,0,0.243,0.0,0.0,0.0,0.0779,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.08,-0.08,2
Home area population density - urban or rural Scotland - Large Urban Area,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.319,0.0,0.0,0.0,0.0779,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.08,-0.08,3
Home area population density - urban or rural Scotland - Large Urban Area,C0724128,Urban tradename,Urban tradename. ,0,0.15,0.0,0.0,0.0,0.0779,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.08,-0.08,99
Home area population density - urban or rural Scotland - Large Urban Area,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.387,0.0,0.0,0.0,0.0779,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.08,-0.08,99
Home area population density - urban or rural Scotland - Large Urban Area,C0549177,Large,"Large. Of considerable or relatively great size, extent, or capacity.",0,0.273,0.0,0.0,0.0,0.0779,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.08,-0.08,2
Home area population density - urban or rural Scotland - Large Urban Area,C1416798,LARGE1 gene,LARGE1 gene. ,0,0.184,0.0,0.0,0.0,0.0779,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.08,-0.08,2
gout,C0018099,Gout,"Gout. Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.",0,0.708,0.0,0.0,0.0,0.0587,0.0,0.223,0.0132,"Non-cancer illness code, self-reported | Array 1__gout",6.78,1215,"Non-cancer illness code, self-reported | Array 1__gout >= 0.50",0.37,0.42,2
Water intake,C0013123,Water consumption,Water consumption. A measurement of a subject's water intake.,0,0.816,0.0,0.0,0.0,0.0498,0.0,0.056,0.0019,Water intake,1.33,8123,1.30 <= Water intake < 9.70,-0.04,0.06,2
Apolipoprotein A Blood biochemistry,C0003592,Apolipoproteins A,"Apolipoproteins A. Structural proteins of the alpha-lipoproteins (HIGH DENSITY LIPOPROTEINS), including APOLIPOPROTEIN A-I and APOLIPOPROTEIN A-II. They can modulate the activity of LECITHIN CHOLESTEROL ACYLTRANSFERASE. These apolipoproteins are low in atherosclerotic patients. They are either absent or present in extremely low plasma concentration in TANGIER DISEASE.",0,0.809,0.0,0.0,0.0,0.048,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,0.17,0.17,2
Apolipoprotein A Blood biochemistry,C0085201,Apolipoprotein A-I,"Apolipoprotein A-I. The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.",0,0.775,0.0,0.0,0.0,0.048,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,0.17,0.17,2
Apolipoprotein A Blood biochemistry,C0003591,Apolipoproteins,Apolipoproteins. Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.,0,0.693,0.0,0.0,0.0,0.048,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,0.17,0.17,2
"Long-standing illness, disability or infirmity",C0231170,Disability,Disability. Any physical or mental impairment that interferes with an individual's ability to perform desired activities.,0,0.495,0.0,0.0,0.0,0.0439,0.0,-0.087,0.0038,"Long-standing illness, disability or infirmity_No",1.28,42073,"Long-standing illness, disability or infirmity_No < 0.50",0.14,0.14,2
"Long-standing illness, disability or infirmity",C0231172,handicapping condition,handicapping condition. ,0,0.617,0.0,0.0,0.0,0.0439,0.0,-0.087,0.0038,"Long-standing illness, disability or infirmity_No",1.28,42073,"Long-standing illness, disability or infirmity_No < 0.50",0.14,0.14,2
Apolipoprotein B Blood biochemistry,C1412471,APOB gene,APOB gene. This gene plays a role in lipid transport.,0,0.67,0.0,1.0,0.3,0.0393,0.0,-0.036,0.0098,Apolipoprotein B Blood biochemistry,1.43,1791,-1.60 <= Apolipoprotein B Blood biochemistry < -1.50,0.2,0.22,2
Apolipoprotein B Blood biochemistry,C0003591,Apolipoproteins,Apolipoproteins. Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.,0,0.646,0.0,1.0,0.3,0.0393,0.0,-0.036,0.0098,Apolipoprotein B Blood biochemistry,1.43,1791,-1.60 <= Apolipoprotein B Blood biochemistry < -1.50,0.2,0.22,2
Alcohol intake frequency. Daily or almost daily,C3841784,Daily or Almost Daily Response,Daily or Almost Daily Response. A subjective response that something happens daily or almost daily.,0,0.461,0.0,1.0,0.5,0.0356,0.0,0.057,0.0015,Alcohol intake frequency._Daily or almost daily,1.31,21296,Alcohol intake frequency._Daily or almost daily >= 0.50,-0.0,0.12,99
Haemoglobin concentration,C0019046,Hemoglobin,Hemoglobin. The oxygen-carrying proteins of ERYTHROCYTES. They are found in all vertebrates and some invertebrates. The number of globin subunits in the hemoglobin quaternary structure differs between species. Structures range from monomeric to a variety of multimeric arrangements.,0,0.724,0.0,0.0,0.0,0.0311,0.0,-0.01,0.0064,Haemoglobin concentration,1.64,1465,-2.80 <= Haemoglobin concentration < -2.10,-0.03,-0.03,2
Haemoglobin concentration,C0019016,Hemoglobin A,Hemoglobin A. Normal adult human hemoglobin. The globin moiety consists of two alpha and two beta chains.,0,0.479,0.0,0.0,0.0,0.0311,0.0,-0.01,0.0064,Haemoglobin concentration,1.64,1465,-2.80 <= Haemoglobin concentration < -2.10,-0.03,-0.03,2
Haemoglobin concentration,C0019020,Hemoglobin C,Hemoglobin C. A commonly occurring abnormal hemoglobin in which lysine replaces a glutamic acid residue at the sixth position of the beta chains. It results in reduced plasticity of erythrocytes.,0,0.614,0.0,0.0,0.0,0.0311,0.0,-0.01,0.0064,Haemoglobin concentration,1.64,1465,-2.80 <= Haemoglobin concentration < -2.10,-0.03,-0.03,2
Urea,C0041942,urea,urea. A compound formed in the liver from ammonia produced by the deamination of amino acids. It is the principal end product of protein catabolism and constitutes about one half of the total urinary solids.,0,0.778,0.0,0.0,0.0,0.0308,0.0,0.092,0.0172,Urea,2.39,1761,1.90 <= Urea < 2.70,0.13,0.13,2
Coffee intake,C0009237,Coffee,Coffee. A beverage made from ground COFFEA beans (SEEDS) infused in hot water. It generally contains CAFFEINE and THEOPHYLLINE unless it is decaffeinated.,0,0.631,0.0,0.0,0.0,0.0295,0.0,-0.049,0.0014,Coffee intake,1.17,25859,-1.20 <= Coffee intake < -0.71,-0.02,-0.02,2
Coffee intake,C1512806,Intake,"Intake. The process of taking in a substance, especially by eating or drinking, or the quantities thereof; admittance of people to a place or organization at a particular time.",0,0.474,0.0,0.0,0.0,0.0295,0.0,-0.049,0.0014,Coffee intake,1.17,25859,-1.20 <= Coffee intake < -0.71,-0.02,-0.02,99
Coffee intake,C3251814,Fluid Intake Measurement,Fluid Intake Measurement. Actions performed to measure the amount of fluid volume taken into the body,0,0.363,0.0,0.0,0.0,0.0295,0.0,-0.049,0.0014,Coffee intake,1.17,25859,-1.20 <= Coffee intake < -0.71,-0.02,-0.02,99
Microalbumin in urine,C2362049,Microalbumin,"Microalbumin. Albumin protein in urine samples, which is a marker for kidney dysfunction. Persistently elevated concentrations of albumin in the urine can be diagnostic for kidney damage caused by diabetes, high blood pressure, heart failure, cirrhosis, or lupus.",0,0.856,0.0,0.0,0.0,0.0284,0.0,0.016,0.0218,Microalbumin in urine,2.64,1415,0.85 <= Microalbumin in urine < 7.50,0.06,0.06,2
Microalbumin in urine,C0042036,Urine,"Urine. Liquid by-product of excretion produced in the kidneys, temporarily stored in the bladder until discharge through the URETHRA.",0,0.597,0.0,0.0,0.0,0.0284,0.0,0.016,0.0218,Microalbumin in urine,2.64,1415,0.85 <= Microalbumin in urine < 7.50,0.06,0.06,2
Microalbumin in urine,C0042037,In Urine,"In Urine. Used for the presence or analysis of substances in the urine, and also for the examination of, or changes in, the urine in disease.",0,0.516,0.0,0.0,0.0,0.0284,0.0,0.016,0.0218,Microalbumin in urine,2.64,1415,0.85 <= Microalbumin in urine < 7.50,0.06,0.06,99
Z51.5 - Palliative care,C0030231,Palliative Care,"Palliative Care. Care alleviating symptoms without curing the underlying disease. (Stedman, 25th ed)",0,0.642,0.0,0.0,0.0,0.0244,0.7013,-0.004,0.0013,Z51.5 - Palliative care,1.02,90035,-0.46 <= Z51.5 - Palliative care < 0.85,-0.0,-0.0,2
Z51.5 - Palliative care,C0557533,Hospice and Palliative Care Nursing,"Hospice and Palliative Care Nursing. A nursing specialty concerned with care of patients facing serious or life-threatening illnesses. The goal of palliative nursing is to prevent and relieve suffering, and to support the best possible quality of life for patients and their families. Hospice nursing is palliative care for people in their final stages of life.",0,0.529,0.0,0.0,0.0,0.0244,0.7013,-0.004,0.0013,Z51.5 - Palliative care,1.02,90035,-0.46 <= Z51.5 - Palliative care < 0.85,-0.0,-0.0,3
Tea intake,C0039400,Tea,"Tea. The infusion of leaves of CAMELLIA SINENSIS (formerly Thea sinensis) as a beverage, the familiar Asian tea, which contains CATECHIN (especially epigallocatechin gallate) and CAFFEINE.",0,0.545,0.0,0.0,0.0,0.0206,0.0,-0.019,0.0006,Tea intake,1.09,34107,-1.00 <= Tea intake < 0.09,0.07,0.08,2
Tea intake,C1512806,Intake,"Intake. The process of taking in a substance, especially by eating or drinking, or the quantities thereof; admittance of people to a place or organization at a particular time.",0,0.508,0.0,0.0,0.0,0.0206,0.0,-0.019,0.0006,Tea intake,1.09,34107,-1.00 <= Tea intake < 0.09,0.07,0.08,99
Tea intake,C3251814,Fluid Intake Measurement,Fluid Intake Measurement. Actions performed to measure the amount of fluid volume taken into the body,0,0.373,0.0,0.0,0.0,0.0206,0.0,-0.019,0.0006,Tea intake,1.09,34107,-1.00 <= Tea intake < 0.09,0.07,0.08,99
(MS) multiple sclerosis genetic risk,C0026221,Mississippi (geographic location),"Mississippi (geographic location). State bounded on the north by Tennessee, on the east by Alabama, on the south by Louisiana and Gulf of Mexico, and on the west by Arkansas and Louisiana.",0,0.234,0.0,0.0,0.0,0.019,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.08,0.1,99
(MS) multiple sclerosis genetic risk,C0026269,Mitral Valve Stenosis,"Mitral Valve Stenosis. Narrowing of the passage through the MITRAL VALVE due to FIBROSIS, and CALCINOSIS in the leaflets and chordal areas. This elevates the left atrial pressure which, in turn, raises pulmonary venous and capillary pressure leading to bouts of DYSPNEA and TACHYCARDIA during physical exertion. RHEUMATIC FEVER is its primary cause.",0,0.244,0.0,0.0,0.0,0.019,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.08,0.1,2
(MS) multiple sclerosis genetic risk,C0026769,Multiple Sclerosis,"Multiple Sclerosis. An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903)",0,0.685,0.0,0.0,0.0,0.019,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.08,0.1,2
(MS) multiple sclerosis genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.602,0.0,0.0,0.0,0.019,0.0011,0.011,0.3067,(MS) multiple sclerosis genetic risk,1.18,2699,(MS) multiple sclerosis genetic risk >= 2.10,0.08,0.1,2
Z92.1 - Personal history of long-term (current) use of anticoagulants,C0424945,Social and personal history,Social and personal history. ,0,0.298,0.0,1.0,0.3,0.0149,0.0112,0.001,0.0017,Z92.1 - Personal history of long-term (current) use of anticoagulants,1.66,2685,Z92.1 - Personal history of long-term (current) use of anticoagulants >= 1.30,0.04,0.04,99
Z92.1 - Personal history of long-term (current) use of anticoagulants,C0003280,Anticoagulants,Anticoagulants. Agents that prevent BLOOD CLOTTING.,0,0.52,0.0,1.0,0.3,0.0149,0.0112,0.001,0.0017,Z92.1 - Personal history of long-term (current) use of anticoagulants,1.66,2685,Z92.1 - Personal history of long-term (current) use of anticoagulants >= 1.30,0.04,0.04,2
Testosterone,C0039601,testosterone,"testosterone. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL.",0,0.768,0.0,0.0,0.0,0.0148,0.2638,-0.016,0.0911,Testosterone,1.41,7043,-1.40 <= Testosterone < -0.47,-0.03,-0.03,2
Testosterone,C4721537,Therapeutic Testosterone,"Therapeutic Testosterone. A synthetic form of the endogenous androgenic steroid testosterone. In vivo, testosterone is irreversibly converted to dihydrotestosterone (DHT) in target tissues by the enzyme 5-alpha reductase. Testosterone or DHT ligand-androgen receptor complexes act as transcription factor complexes, stimulating the expression of various responsive genes. DHT binds with higher affinity to androgen receptors than testosterone, activating gene expression more efficiently. In addition, testosterone is irreversibly converted to estradiol by the enzyme complex aromatase, particularly in the liver and adipose tissue. Testosterone and DHT promote the development and maintenance of male sex characteristics related to the internal and external genitalia, skeletal muscle, and hair follicles; estradiol promotes epiphyseal maturation and bone mineralization. Due to rapid metabolism by the liver, therapeutic testosterone is generally administered as an ester derivative.",0,0.646,0.0,0.0,0.0,0.0148,0.2638,-0.016,0.0911,Testosterone,1.41,7043,-1.40 <= Testosterone < -0.47,-0.03,-0.03,99
Testosterone,C0523912,Testosterone measurement,Testosterone measurement. The determination of the amount of testosterone present in a sample.,0,0.758,0.0,0.0,0.0,0.0148,0.2638,-0.016,0.0911,Testosterone,1.41,7043,-1.40 <= Testosterone < -0.47,-0.03,-0.03,2
Triglycerides Blood biochemistry,C0202236,Triglycerides measurement,Triglycerides measurement. A quantitative measurement of the amount of triglyceride present in a sample.,0,0.904,0.0,1.0,0.5,0.014,0.0,0.084,0.0394,Triglycerides Blood biochemistry,1.92,2452,Triglycerides Blood biochemistry >= 2.50,0.16,0.16,99
Home area population density - urban or rural Scotland - Other Urban Area,C0178587,density,density. The amount of something per unit size.,0,0.276,0.0,0.0,0.0,0.0136,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.0,0.01,2
Home area population density - urban or rural Scotland - Other Urban Area,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.339,0.0,0.0,0.0,0.0136,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.0,0.01,3
Home area population density - urban or rural Scotland - Other Urban Area,C0724128,Urban tradename,Urban tradename. ,0,0.187,0.0,0.0,0.0,0.0136,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.0,0.01,99
Home area population density - urban or rural Scotland - Other Urban Area,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.386,0.0,0.0,0.0,0.0136,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.0,0.01,99
Home area population density - urban or rural Scotland - Other Urban Area,C0178876,urban area,"urban area. of, relating to, or located in a city area.",0,0.334,0.0,0.0,0.0,0.0136,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.0,0.01,3
Chronic renal failure [CKD],C0022661,"Kidney Failure, Chronic","Kidney Failure, Chronic. The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.",0,0.805,0.0,0.0,0.0,0.013,0.0657,0.025,0.0027,Chronic renal failure [CKD],0.97,89920,-0.59 <= Chronic renal failure [CKD] < 0.34,0.16,0.16,2
Chronic renal failure [CKD],C1561643,Chronic Kidney Diseases,Chronic Kidney Diseases. Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.,0,0.72,0.0,0.0,0.0,0.013,0.0657,0.025,0.0027,Chronic renal failure [CKD],0.97,89920,-0.59 <= Chronic renal failure [CKD] < 0.34,0.16,0.16,2
Chronic renal failure [CKD],C2316810,Chronic kidney disease stage 5,Chronic kidney disease stage 5. Long-standing and persistent renal disease with glomerular filtration rate (GFR) less than 15 ml/min.,0,0.532,0.0,0.0,0.0,0.013,0.0657,0.025,0.0027,Chronic renal failure [CKD],0.97,89920,-0.59 <= Chronic renal failure [CKD] < 0.34,0.16,0.16,2
(HDL) high density lipoprotein cholesterol genetic risk,C0023821,High Density Lipoproteins,"High Density Lipoproteins. A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.",0,0.479,0.0,1.0,0.2,0.0129,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.21,0.21,2
(HDL) high density lipoprotein cholesterol genetic risk,C0062709,"Lipoproteins, HDL2","Lipoproteins, HDL2. Low-density subclass of the high-density lipoproteins, with particle sizes between 8 to 13 nm.",0,0.423,0.0,1.0,0.2,0.0129,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.21,0.21,2
(HDL) high density lipoprotein cholesterol genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.753,0.0,1.0,0.2,0.0129,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.21,0.21,2
Birth weight,C0005612,Birth Weight,Birth Weight. The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.,0,0.866,0.0,0.0,0.0,0.0127,0.0,-0.017,0.0017,Birth weight,1.03,72146,-3.70 <= Birth weight < 0.07,0.08,0.08,2
Birth weight,C0024032,Low Birth Weights,Low Birth Weights. A birth weight that is less than 2500 grams.,0,0.722,0.0,0.0,0.0,0.0127,0.0,-0.017,0.0017,Birth weight,1.03,72146,-3.70 <= Birth weight < 0.07,0.08,0.08,2
SHBG,C0036883,Sex Hormone-Binding Globulin,"Sex Hormone-Binding Globulin. A glycoprotein migrating as a beta-globulin. Its molecular weight, 52,000 or 95,000-115,000, indicates that it exists as a dimer. The protein binds testosterone, dihydrotestosterone, and estradiol in the plasma. Sex hormone-binding protein has the same amino acid sequence as ANDROGEN-BINDING PROTEIN. They differ by their sites of synthesis and post-translational oligosaccharide modifications.",0,0.45,0.0,0.0,0.0,0.0125,0.0,-0.071,0.0511,SHBG,1.68,2712,SHBG < -1.40,0.03,0.1,2
SHBG,C0312446,Somatotropin binding globulin,Somatotropin binding globulin. ,0,0.518,0.0,0.0,0.0,0.0125,0.0,-0.071,0.0511,SHBG,1.68,2712,SHBG < -1.40,0.03,0.1,99
SHBG,C1366439,SHBG gene,SHBG gene. This gene is involved in the regulation of steroid hormones.,0,0.622,0.0,0.0,0.0,0.0125,0.0,-0.071,0.0511,SHBG,1.68,2712,SHBG < -1.40,0.03,0.1,2
Atrial fibrillation and flutter,C0344434,Atrial Fibrillation by ECG Finding,"Atrial Fibrillation by ECG Finding. An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. (CDISC)",0,0.653,0.0,1.0,0.2,0.0121,0.1973,-0.001,0.002,Atrial fibrillation and flutter,2.0,1394,-5.10 <= Atrial fibrillation and flutter < -1.20,-0.05,0.19,99
Atrial fibrillation and flutter,C0016385,Cardiac Flutter,Cardiac Flutter. ,0,0.783,0.0,1.0,0.2,0.0121,0.1973,-0.001,0.002,Atrial fibrillation and flutter,2.0,1394,-5.10 <= Atrial fibrillation and flutter < -1.20,-0.05,0.19,2
Atrial fibrillation and flutter,C2242390,Flutter (respiratory device),Flutter (respiratory device). ,0,0.541,0.0,1.0,0.2,0.0121,0.1973,-0.001,0.002,Atrial fibrillation and flutter,2.0,1394,-5.10 <= Atrial fibrillation and flutter < -1.20,-0.05,0.19,99
Arthropathy NOS,C0022408,Arthropathy,Arthropathy. Diseases involving the JOINTS.,0,0.952,0.0,0.0,0.0,0.0105,0.0952,-0.004,0.0009,Arthropathy NOS,1.52,1456,-4.50 <= Arthropathy NOS < -1.90,0.21,0.3,2
Townsend deprivation index at recruitment,C2949735,Recruitment,"Recruitment. The process of enrolling, enlisting, or adding individuals to a group.",0,0.144,0.0,0.0,0.0,0.0097,0.0,0.025,0.0094,Townsend deprivation index at recruitment,1.19,10276,1.40 <= Townsend deprivation index at recruitment < 2.90,-0.02,-0.02,99
(CVD) cardiovascular disease genetic risk,C0007820,Cerebrovascular Disorders,"Cerebrovascular Disorders. A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.",0,0.332,0.0,1.0,0.3,0.0086,0.0,0.028,0.3075,(CVD) cardiovascular disease genetic risk,1.09,30971,0.38 <= (CVD) cardiovascular disease genetic risk < 3.00,0.11,0.16,2
(CVD) cardiovascular disease genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.737,0.0,1.0,0.3,0.0086,0.0,0.028,0.3075,(CVD) cardiovascular disease genetic risk,1.09,30971,0.38 <= (CVD) cardiovascular disease genetic risk < 3.00,0.11,0.16,2
"N18.3 - Chronic kidney disease, stage",C1561643,Chronic Kidney Diseases,Chronic Kidney Diseases. Impairment of the renal function secondary to chronic kidney damage persisting for three or more months.,0,0.568,0.0,0.0,0.0,0.0083,0.1787,0.012,0.0011,"N18.3 - Chronic kidney disease, stage 3",0.98,90180,"-0.83 <= N18.3 - Chronic kidney disease, stage 3 < 1.20",0.04,0.04,2
Congestive heart failure (CHF) NOS,C0018802,Congestive heart failure,"Congestive heart failure. Heart failure accompanied by EDEMA, such as swelling of the legs and ankles and congestion in the lungs.",0,0.712,0.0,0.0,0.0,0.0079,0.07,0.007,0.0016,Congestive heart failure (CHF) NOS,0.98,90159,-0.20 <= Congestive heart failure (CHF) NOS < 0.76,0.11,0.16,2
(RA) rheumatoid arthritis genetic risk,C0038013,Ankylosing spondylitis,"Ankylosing spondylitis. A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.",0,0.422,0.0,1.0,0.3,0.0076,0.1424,0.003,0.3073,(RA) rheumatoid arthritis genetic risk,1.09,6905,1.50 <= (RA) rheumatoid arthritis genetic risk < 3.70,0.11,0.13,2
(RA) rheumatoid arthritis genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.602,0.0,1.0,0.3,0.0076,0.1424,0.003,0.3073,(RA) rheumatoid arthritis genetic risk,1.09,6905,1.50 <= (RA) rheumatoid arthritis genetic risk < 3.70,0.11,0.13,2
(HT) hypertension genetic risk,C0677607,Hashimoto Disease,Hashimoto Disease. An autoimmune disorder caused by the production of autoantibodies against thyroid tissue. There is progressive destruction of the thyroid follicles leading to hypothyroidism.,0,0.258,0.0,1.0,0.2,0.0076,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.04,0.08,2
(HT) hypertension genetic risk,C0235222,Diastolic hypertension,Diastolic hypertension. Hypertension characterized diastolic blood pressure greater than 90 mmHg on two occasions.,0,0.385,0.0,1.0,0.2,0.0076,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.04,0.08,2
(HT) hypertension genetic risk,C1696708,Prehypertension,"Prehypertension. Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.",0,0.622,0.0,1.0,0.2,0.0076,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.04,0.08,2
(HT) hypertension genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.691,0.0,1.0,0.2,0.0076,0.0,0.035,0.3074,(HT) hypertension genetic risk,1.23,10112,(HT) hypertension genetic risk >= 1.20,0.04,0.08,2
Date of all cause dementia report,C0015127,Etiology aspects,Etiology aspects. Used with diseases for causative agents including microorganisms and includes environmental and social factors and personal habits as contributing factors. It includes pathogenesis.,0,0.161,0.0,0.0,0.0,0.0075,0.0,-0.023,0.0019,Date of all cause dementia report,1.0,91105,-5.20 <= Date of all cause dementia report < 1.10,0.17,0.17,99
Date of all cause dementia report,C0011265,Presenile dementia,Presenile dementia. The presence of dementia in an individual younger than age sixty five.,0,0.364,0.0,0.0,0.0,0.0075,0.0,-0.023,0.0019,Date of all cause dementia report,1.0,91105,-5.20 <= Date of all cause dementia report < 1.10,0.17,0.17,2
Date of all cause dementia report,C0497327,Dementia,"Dementia. An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.",0,0.442,0.0,0.0,0.0,0.0075,0.0,-0.023,0.0019,Date of all cause dementia report,1.0,91105,-5.20 <= Date of all cause dementia report < 1.10,0.17,0.17,2
Sex,C0009253,Coitus,"Coitus. The sexual union of a male and a female, a term used for human only.",0,0.731,0.0,1.0,0.3,0.0069,0.0,-0.034,0.0006,Sex,1.05,72375,Sex < 0.71,0.04,0.04,2
Sex,C0036864,Sex Behavior,Sex Behavior. Sexual activities of humans.,0,0.666,0.0,1.0,0.3,0.0069,0.0,-0.034,0.0006,Sex,1.05,72375,Sex < 0.71,0.04,0.04,2
Apolipoprotein A1,C0085201,Apolipoprotein A-I,"Apolipoprotein A-I. The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.",0,0.887,0.0,0.0,0.0,0.0068,0.007,0.004,0.0564,Apolipoprotein A1,1.31,2405,2.40 <= Apolipoprotein A1 < 5.30,0.13,0.13,2
Apolipoprotein A1,C1412468,APOA1 gene,APOA1 gene. This gene is involved in cholesterol transport and metabolism.,0,0.758,0.0,0.0,0.0,0.0068,0.007,0.004,0.0564,Apolipoprotein A1,1.31,2405,2.40 <= Apolipoprotein A1 < 5.30,0.13,0.13,2
Apolipoprotein A1,C1677784,"APOA1 protein, human","APOA1 protein, human. Apolipoprotein A-I (267 aa, ~31 kDa) is encoded by the human APOA1 gene. This protein is involved in the transport and metabolism of cholesterol.",0,0.845,0.0,0.0,0.0,0.0068,0.007,0.004,0.0564,Apolipoprotein A1,1.31,2405,2.40 <= Apolipoprotein A1 < 5.30,0.13,0.13,99
dietary changes in the last 5 years,C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.251,0.0,1.0,0.3,0.0066,0.0,-0.033,0.0005,Major dietary changes in the last 5 years_No,1.11,39187,Major dietary changes in the last 5 years_No < 0.50,0.09,0.09,99
dietary changes in the last 5 years,C0443172,Changed status,Changed status. ,0,0.222,0.0,1.0,0.3,0.0066,0.0,-0.033,0.0005,Major dietary changes in the last 5 years_No,1.11,39187,Major dietary changes in the last 5 years_No < 0.50,0.09,0.09,99
Overall health rating Excellent,C1548784,Excellent - Specimen Quality,Excellent - Specimen Quality. ,0,0.34,0.0,0.0,0.0,0.0065,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.02,-0.02,99
Overall health rating Excellent,C1551022,Excellent - LanguageAbilityProficiency,Excellent - LanguageAbilityProficiency. ,0,0.216,0.0,0.0,0.0,0.0065,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.02,-0.02,99
Overall health rating Excellent,C1961136,Excellent (qualifier value),Excellent (qualifier value). Conforming to the highest quality or standard.,0,0.509,0.0,0.0,0.0,0.0065,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.02,-0.02,99
Albumin,C0001924,Albumins,"Albumins. Water-soluble proteins found in egg whites, blood, lymph, and other tissues and fluids. They coagulate upon heating.",0,0.835,0.0,0.0,0.0,0.0062,0.0785,-0.003,0.0705,Albumin,1.36,1072,Albumin < -2.80,0.06,0.06,2
Albumin,C1412332,ALB gene,ALB gene. ,0,0.596,0.0,0.0,0.0,0.0062,0.0785,-0.003,0.0705,Albumin,1.36,1072,Albumin < -2.80,0.06,0.06,2
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",C0344434,Atrial Fibrillation by ECG Finding,"Atrial Fibrillation by ECG Finding. An electrocardiographic finding of a supraventricular arrhythmia characterized by the replacement of consistent P waves by rapid oscillations or fibrillatory waves that vary in size, shape and timing and are accompanied by an irregularly irregular ventricular response. (CDISC)",0,0.69,0.0,1.0,0.2,0.0054,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",-0.02,0.15,99
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",C0004239,Atrial Flutter,"Atrial Flutter. Rapid, irregular atrial contractions caused by a block of electrical impulse conduction in the right atrium and a reentrant wave front traveling up the inter-atrial septum and down the right atrial free wall or vice versa. Unlike ATRIAL FIBRILLATION which is caused by abnormal impulse generation, typical atrial flutter is caused by abnormal impulse conduction. As in atrial fibrillation, patients with atrial flutter cannot effectively pump blood into the lower chambers of the heart (HEART VENTRICLES).",0,0.627,0.0,1.0,0.2,0.0054,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",-0.02,0.15,2
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",C0344423,Atrial Flutter by ECG Finding,"Atrial Flutter by ECG Finding. An electrocardiographic finding of an organized, regular atrial rhythm with atrial rate of 240-340 beats per minute. Multiple P waves typically appear in the inferior leads in a saw tooth like pattern between the QRS complexes. (CDISC)",0,0.667,0.0,1.0,0.2,0.0054,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",-0.02,0.15,99
Home area population density - urban or rural England/Wales - Urban - less sparse,C0178587,density,density. The amount of something per unit size.,0,0.229,0.0,0.0,0.0,0.005,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.03,-0.03,2
Home area population density - urban or rural England/Wales - Urban - less sparse,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.328,0.0,0.0,0.0,0.005,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.03,-0.03,3
Home area population density - urban or rural England/Wales - Urban - less sparse,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.283,0.0,0.0,0.0,0.005,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.03,-0.03,99
Home area population density - urban or rural England/Wales - Urban - less sparse,C0439092,Less Than,Less Than. A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.,0,0.307,0.0,0.0,0.0,0.005,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.03,-0.03,99
Home area population density - urban or rural England/Wales - Urban - less sparse,C0547044,Smaller,"Smaller. Of lower rank, degree, or importance; of reduced size, extent, or degree; more limited in quantity.",0,0.315,0.0,0.0,0.0,0.005,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.03,-0.03,99
Essential hypertension,C0085580,Essential Hypertension,"Essential Hypertension. Hypertension that occurs without known cause, or preexisting renal disease. Associated polymorphisms for a number of genes have been identified, including AGT, GNB3, and ECE1. OMIM: 145500",0,0.751,0.0,0.0,0.0,0.0046,0.0,-0.021,0.0038,Essential hypertension,1.68,5491,-3.90 <= Essential hypertension < -1.50,0.09,0.1,2
Apolipoprotein B to Apolipoprotein A1 ratio,C1412471,APOB gene,APOB gene. This gene plays a role in lipid transport.,0,0.641,0.0,1.0,0.1,0.0043,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,0.16,0.16,2
Apolipoprotein B to Apolipoprotein A1 ratio,C0003591,Apolipoproteins,Apolipoproteins. Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.,0,0.587,0.0,1.0,0.1,0.0043,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,0.16,0.16,2
Apolipoprotein B to Apolipoprotein A1 ratio,C0085201,Apolipoprotein A-I,"Apolipoprotein A-I. The most abundant protein component of HIGH DENSITY LIPOPROTEINS or HDL. This protein serves as an acceptor for CHOLESTEROL released from cells thus promoting efflux of cholesterol to HDL then to the LIVER for excretion from the body (reverse cholesterol transport). It also acts as a cofactor for LECITHIN CHOLESTEROL ACYLTRANSFERASE that forms CHOLESTEROL ESTERS on the HDL particles. Mutations of this gene APOA1 cause HDL deficiency, such as in FAMILIAL ALPHA LIPOPROTEIN DEFICIENCY DISEASE and in some patients with TANGIER DISEASE.",0,0.632,0.0,1.0,0.1,0.0043,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,0.16,0.16,2
Apolipoprotein B to Apolipoprotein A1 ratio,C1412468,APOA1 gene,APOA1 gene. This gene is involved in cholesterol transport and metabolism.,0,0.595,0.0,1.0,0.1,0.0043,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,0.16,0.16,2
Apolipoprotein B to Apolipoprotein A1 ratio,C1677784,"APOA1 protein, human","APOA1 protein, human. Apolipoprotein A-I (267 aa, ~31 kDa) is encoded by the human APOA1 gene. This protein is involved in the transport and metabolism of cholesterol.",0,0.587,0.0,1.0,0.1,0.0043,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,0.16,0.16,99
Apolipoprotein B to Apolipoprotein A1 ratio,C0456603,Ratio,Ratio. Quotient of quantities of the same kind for different components within the same system.,0,0.271,0.0,1.0,0.1,0.0043,0.0,-0.033,0.1361,Apolipoprotein B to Apolipoprotein A1 ratio,1.28,5102,-2.50 <= Apolipoprotein B to Apolipoprotein A1 ratio < -1.60,0.16,0.16,2
"M15.9 - Polyarthrosis, unspecified",C0702154,Polyarthropathy,Polyarthropathy. ,0,0.766,0.0,0.0,0.0,0.0039,0.0127,0.01,0.0002,"M15.9 - Polyarthrosis, unspecified",0.99,90102,"-0.16 <= M15.9 - Polyarthrosis, unspecified < 0.86",0.2,0.2,2
Asthma,C0004096,Asthma,"Asthma. A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).",0,0.508,0.0,0.0,0.0,0.0039,0.0356,-0.005,0.0003,Asthma,1.14,1677,-2.60 <= Asthma < -0.08,0.09,0.16,2
Diverticulosis,C1510475,Diverticulosis,"Diverticulosis. A finding indicating the presence of multiple pouches, usually in the colonic or gastric wall.",0,0.798,0.0,0.0,0.0,0.0037,0.7367,0.002,0.0007,Diverticulosis,1.38,1508,-1.40 <= Diverticulosis < -0.09,0.33,0.33,2
Diverticulosis,C0810029,Diverticulosis and Diverticulitis,"Diverticulosis and Diverticulitis. <p>Diverticula are small pouches that bulge outward through the colon, or large intestine. If you have these pouches, you have a condition called diverticulosis. It becomes more common as people age. About half of all people over age 60 have it. Doctors believe the main cause is a low-fiber diet.</p> <p>Most people with diverticulosis don't have symptoms. Sometimes it causes mild cramps, bloating or constipation. Diverticulosis is often found through tests ordered for something else. For example, it is often found during a colonoscopy to screen for cancer. A high-fiber diet and mild pain reliever will often relieve symptoms.</p> <p>If the pouches become inflamed or infected, you have a condition called diverticulitis. The most common symptom is abdominal pain, usually on the left side. You may also have fever, nausea, vomiting, chills, cramping, and constipation. In serious cases, diverticulitis can lead to bleeding, tears, or blockages. Your doctor will do a physical exam and imaging tests to diagnose it. Treatment may include antibiotics, pain relievers, and a liquid diet. A serious case may require a hospital stay or surgery.</p> <p class="""">NIH: National Institute of Diabetes and Digestive and Kidney Diseases</p>",0,0.834,0.0,0.0,0.0,0.0037,0.7367,0.002,0.0007,Diverticulosis,1.38,1508,-1.40 <= Diverticulosis < -0.09,0.33,0.33,99
"Other chronic ischemic heart disease, unspecified",C0264694,Chronic myocardial ischemia,Chronic myocardial ischemia. ,0,0.903,0.0,0.0,0.0,0.0037,0.2562,0.012,0.0017,"Other chronic ischemic heart disease, unspecified",1.57,3125,"Other chronic ischemic heart disease, unspecified >= 1.30",0.14,0.14,2
Chemotherapy,C0013216,Pharmacotherapy,Pharmacotherapy. The use of DRUGS to treat a DISEASE or its symptoms. One example is the use of ANTINEOPLASTIC AGENTS to treat CANCER.,0,0.772,0.0,0.0,0.0,0.0035,0.0266,0.011,0.0004,Chemotherapy,1.0,86391,-0.03 <= Chemotherapy < 0.72,0.03,0.03,2
Chemotherapy,C0013217,pharmacotherapeutic,"pharmacotherapeutic. Used with disease headings for the treatment of disease by the administration of drugs, chemicals, and antibiotics. For diet therapy and radiotherapy, use specific subheadings. Excludes immunotherapy for which ""therapy"" is used.",0,0.673,0.0,0.0,0.0,0.0035,0.0266,0.011,0.0004,Chemotherapy,1.0,86391,-0.03 <= Chemotherapy < 0.72,0.03,0.03,99
Chemotherapy,C0392920,Chemotherapy Regimen,Chemotherapy Regimen. application of the beneficial effects of drugs to control or cure neoplastic growth.,0,0.783,0.0,0.0,0.0,0.0035,0.0266,0.011,0.0004,Chemotherapy,1.0,86391,-0.03 <= Chemotherapy < 0.72,0.03,0.03,2
(AD) alzheimer's disease genetic risk,C0002395,Alzheimer's Disease,"Alzheimer's Disease. A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)",0,0.675,0.0,0.0,0.0,0.0033,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,0.19,0.2,2
(AD) alzheimer's disease genetic risk,C1863052,"ALZHEIMER DISEASE, FAMILIAL, 1","ALZHEIMER DISEASE, FAMILIAL, 1. Alzheimer's disease caused by mutation(s) in the APP gene, encoding amyloid-beta A4 protein. The onset of this condition typically occurs before age 65.",0,0.763,0.0,0.0,0.0,0.0033,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,0.19,0.2,99
(AD) alzheimer's disease genetic risk,C1843013,"Alzheimer disease, familial, type 3","Alzheimer disease, familial, type 3. Alzheimer's disease with an early onset (starts before the age of 65). It is caused by mutations in the PSEN1 gene.",0,0.664,0.0,0.0,0.0,0.0033,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,0.19,0.2,2
(AD) alzheimer's disease genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.622,0.0,0.0,0.0,0.0033,0.2627,-0.003,0.3071,(AD) alzheimer's disease genetic risk,1.01,5427,(AD) alzheimer's disease genetic risk >= 1.80,0.19,0.2,2
Acetone,C0001002,acetone,acetone. A colorless liquid used as a solvent and an antiseptic. It is one of the ketone bodies produced during ketoacidosis.,0,0.864,0.0,0.0,0.0,0.0032,0.0,0.024,0.0816,Acetone,1.36,2195,2.40 <= Acetone < 10.00,0.04,0.04,2
(VTE) venous thromboembolic disease genetic risk,C1997614,Thromboembolism of vein,Thromboembolism of vein. ,0,0.361,0.0,0.0,0.0,0.0031,0.7621,0.001,0.3077,(VTE) venous thromboembolic disease genetic risk,1.0,91418,(VTE) venous thromboembolic disease genetic risk < 3.60,0.05,0.05,2
(VTE) venous thromboembolic disease genetic risk,C1517512,Genetic Risk,Genetic Risk. Risk of developing a disease based on a patient's heredity,0,0.708,0.0,0.0,0.0,0.0031,0.7621,0.001,0.3077,(VTE) venous thromboembolic disease genetic risk,1.0,91418,(VTE) venous thromboembolic disease genetic risk < 3.60,0.05,0.05,2
Other ill-defined and unknown causes of morbidity and mortality,C0026538,Morbidity - disease rate,Morbidity - disease rate. The proportion of patients with a particular disease during a given year per given unit of population.,0,0.255,0.0,0.0,0.0,0.0029,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.25,0.25,2
Other ill-defined and unknown causes of morbidity and mortality,C5669240,Morbidity Rate,"Morbidity Rate. A measure of the frequency of occurrence of a specific disease, injury, or disability in a defined population during a specified interval. [After Principles of Epidemiology in Public Health Practice, Third Edition. An Introduction to Applied Epidemiology and Biostatistics]",0,0.254,0.0,0.0,0.0,0.0029,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.25,0.25,99
Other ill-defined and unknown causes of morbidity and mortality,C0026565,Mortality Vital Statistics,Mortality Vital Statistics. All deaths reported in a given population.,0,0.406,0.0,0.0,0.0,0.0029,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.25,0.25,2
Other ill-defined and unknown causes of morbidity and mortality,C0026566,Aspects of mortality statistics,"Aspects of mortality statistics. Used with human and veterinary diseases for mortality statistics. For deaths resulting from various procedures statistically but for a death resulting in a specific case, use FATAL OUTCOME, not /mortality.",0,0.358,0.0,0.0,0.0,0.0029,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.25,0.25,99
Meat substitutes - vegetarian,C0042441,Vegetarian (finding,"Vegetarian (finding. A person who eats no meat; some may eat fish, eggs, or dairy products.",0,0.727,0.0,0.0,0.0,0.0028,0.255,0.004,0.0001,Meat substitutes - vegetarian,1.01,80042,-0.18 <= Meat substitutes - vegetarian < 3.10,-0.02,-0.02,2
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0178587,density,density. The amount of something per unit size.,0,0.247,0.0,0.0,0.0,0.0024,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.04,-0.04,2
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.269,0.0,0.0,0.0,0.0024,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.04,-0.04,3
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.268,0.0,0.0,0.0,0.0024,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.04,-0.04,99
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0557750,Towns,Towns. Human settlements larger than a village but smaller than a city.,0,0.444,0.0,0.0,0.0,0.0024,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.04,-0.04,99
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0439092,Less Than,Less Than. A statement about the relative size or order of two objects specifying that an object of interest is smaller than another object in quantity or measure or value or status.,0,0.268,0.0,0.0,0.0,0.0024,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.04,-0.04,99
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,C0547044,Smaller,"Smaller. Of lower rank, degree, or importance; of reduced size, extent, or degree; more limited in quantity.",0,0.311,0.0,0.0,0.0,0.0024,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.04,-0.04,99
Diaphragmatic hernia,C0019284,Diaphragmatic Hernia,Diaphragmatic Hernia. Protrusion of abdominal structures into the THORAX as a result of congenital or traumatic defects in the respiratory DIAPHRAGM.,0,0.889,0.0,0.0,0.0,0.0024,0.3485,0.002,0.0001,Diaphragmatic hernia,1.13,2977,-4.40 <= Diaphragmatic hernia < -0.05,0.18,0.2,2
Diaphragmatic hernia,C0235833,Congenital diaphragmatic hernia,Congenital diaphragmatic hernia. Diaphragmatic hernia that is present at birth.,0,0.825,0.0,0.0,0.0,0.0024,0.3485,0.002,0.0001,Diaphragmatic hernia,1.13,2977,-4.40 <= Diaphragmatic hernia < -0.05,0.18,0.2,2
Diaphragmatic hernia,C1840643,DIAPHRAGMATIC HERNIA 1,DIAPHRAGMATIC HERNIA 1. ,0,0.912,0.0,0.0,0.0,0.0024,0.3485,0.002,0.0001,Diaphragmatic hernia,1.13,2977,-4.40 <= Diaphragmatic hernia < -0.05,0.18,0.2,99
3-Hydroxybutyrate,C0106006,3-Hydroxybutyrate,3-Hydroxybutyrate. A hydroxy fatty acid anion and ketone body synthesized in the liver from acetyl-Coenzyme A (acetyl-CoA) by the enzyme 3-hydroxybutyrate dehydrogenase. 3-hydroxybutyrate can be used as an energy source when glucose levels drop. Elevated urine and serum levels of 3-hydroxybutyrate are seen in ketosis and ketoacidosis.,0,0.767,0.0,0.0,0.0,0.0024,0.0,0.023,0.1431,3-Hydroxybutyrate,1.11,14658,-0.49 <= 3-Hydroxybutyrate < -0.02,0.0,0.0,2
Acetoacetate,C0000988,Acetoacetates,Acetoacetates. Salts and derivatives of acetoacetic acid.,0,0.86,0.0,0.0,0.0,0.0023,0.0,0.034,0.1366,Acetoacetate,1.24,9070,Acetoacetate >= 0.62,-0.0,-0.0,2
Acetoacetate,C0220778,acetoacetate,acetoacetate. ,0,0.987,0.0,0.0,0.0,0.0023,0.0,0.034,0.1366,Acetoacetate,1.24,9070,Acetoacetate >= 0.62,-0.0,-0.0,2
Acetoacetate,C0392886,Acetoacetate measurement,Acetoacetate measurement. The determination of the amount of acetoacetic acid present in a sample.,0,0.665,0.0,0.0,0.0,0.0023,0.0,0.034,0.1366,Acetoacetate,1.24,9070,Acetoacetate >= 0.62,-0.0,-0.0,99
Other peripheral nerve disorders,C4721453,Peripheral Nervous System Diseases,"Peripheral Nervous System Diseases. Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.",0,0.86,0.0,0.0,0.0,0.0023,0.0387,0.008,0.0004,Other peripheral nerve disorders,1.11,1588,-11.00 <= Other peripheral nerve disorders < -0.25,0.04,0.04,2
Concentration of IDL Particles,C0086045,Mental concentration,"Mental concentration. The act or process of concentrating, focusing the attention and mental energy on a single object to the exclusion of others.",0,0.152,0.0,0.0,0.0,0.0022,0.0,-0.033,0.0604,Concentration of IDL Particles,1.43,2252,-3.80 <= Concentration of IDL Particles < -2.40,0.01,0.09,2
hypertension,C0235222,Diastolic hypertension,Diastolic hypertension. Hypertension characterized diastolic blood pressure greater than 90 mmHg on two occasions.,0,0.469,0.0,1.0,0.3,0.0021,0.0,0.084,0.0034,"Non-cancer illness code, self-reported | Array 0__hypertension",1.36,29822,"Non-cancer illness code, self-reported | Array 0__hypertension >= 0.61",0.1,0.13,2
hypertension,C1696708,Prehypertension,"Prehypertension. Blood pressure levels that are between normotension and hypertension. Individuals with prehypertension are at a higher risk for developing cardiovascular diseases. Generally, prehypertension is defined as SYSTOLIC PRESSURE of 131-139 mm Hg and/or DIASTOLIC PRESSURE of 81-89 when the optimal is 120/80 mm Hg. For diabetics and other metabolism diseases the prehypertension is around 110-129/70-79 mm Hg.",0,0.622,0.0,1.0,0.3,0.0021,0.0,0.084,0.0034,"Non-cancer illness code, self-reported | Array 0__hypertension",1.36,29822,"Non-cancer illness code, self-reported | Array 0__hypertension >= 0.61",0.1,0.13,2
Cancer of bronchus; lung,C0007121,Bronchogenic Carcinoma,Bronchogenic Carcinoma. Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA.,0,0.815,0.0,0.0,0.0,0.002,0.426,0.005,0.0004,Cancer of bronchus; lung,1.0,90707,-0.09 <= Cancer of bronchus; lung < 0.51,0.16,0.16,2
Cancer of bronchus; lung,C0024109,Lung,Lung. Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.,0,0.427,0.0,0.0,0.0,0.002,0.426,0.005,0.0004,Cancer of bronchus; lung,1.0,90707,-0.09 <= Cancer of bronchus; lung < 0.51,0.16,0.16,2
Cancer of bronchus; lung,C4037972,Chest>Lung,Chest>Lung. ,0,0.447,0.0,0.0,0.0,0.002,0.426,0.005,0.0004,Cancer of bronchus; lung,1.0,90707,-0.09 <= Cancer of bronchus; lung < 0.51,0.16,0.16,99
Alanine,C0001898,alanine,"alanine. A non-essential amino acid that occurs in high levels in its free state in plasma. It is produced from pyruvate by transamination. It is involved in sugar and acid metabolism, increases IMMUNITY, and provides energy for muscle tissue, BRAIN, and the CENTRAL NERVOUS SYSTEM.",0,0.775,0.0,0.0,0.0,0.002,0.0,0.025,0.1066,Alanine,1.4,1058,Alanine >= 3.10,0.02,0.02,2
Concentration of Very Large VLDL Particles,C0023825,Very low density lipoprotein,"Very low density lipoprotein. A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues.",0,0.631,0.0,0.0,0.0,0.0019,0.0,0.029,0.0705,Concentration of Very Large VLDL Particles,1.4,2817,2.10 <= Concentration of Very Large VLDL Particles < 5.40,-0.02,0.07,2
Concentration of Very Large VLDL Particles,C0597177,Particle,Particle. An object with finite mass and size parameters.,0,0.246,0.0,0.0,0.0,0.0019,0.0,0.029,0.0705,Concentration of Very Large VLDL Particles,1.4,2817,2.10 <= Concentration of Very Large VLDL Particles < 5.40,-0.02,0.07,2
Hemorrhage or hematoma complicating a procedure,C0029163,Oral Hemorrhage,"Oral Hemorrhage. Bleeding from the blood vessels of the mouth, which may occur as a result of injuries to the mouth, accidents in oral surgery, or diseases of the gums.",0,0.325,0.0,2.0,0.3,0.0018,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.05,0.05,2
Hemorrhage or hematoma complicating a procedure,C0426747,Bleeding from anus,Bleeding from anus. Bleeding originating from the anal area.,0,0.419,0.0,2.0,0.3,0.0018,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.05,0.05,2
Hemorrhage or hematoma complicating a procedure,C0018944,Hematoma,"Hematoma. A collection of blood outside the BLOOD VESSELS. Hematoma can be localized in an organ, space, or tissue.",0,0.568,0.0,2.0,0.3,0.0018,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.05,0.05,2
Hemorrhage or hematoma complicating a procedure,C1522701,Complicating,Complicating. Making more complex or intricate.,0,0.17,0.0,2.0,0.3,0.0018,0.0031,-0.004,0.0002,Hemorrhage or hematoma complicating a procedure,1.24,938,0.28 <= Hemorrhage or hematoma complicating a procedure < 9.30,0.05,0.05,99
Acetate,C0000975,acetate,"acetate. Salt or ester form of acetic acid. Acetate is the most common building block for biosynthesis, such as fatty acids.",0,0.788,0.0,0.0,0.0,0.0017,0.0,-0.004,0.1028,Acetate,1.0,86320,Acetate < 0.15,-0.04,-0.04,2
"dietary changes in the last 5 years Yes, because of other reasons",C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.283,0.0,0.0,0.0,0.0017,0.0065,-0.009,0.0,"Major dietary changes in the last 5 years_Yes, because of other reasons",1.02,67117,"Major dietary changes in the last 5 years_Yes, because of other reasons < 0.50",0.17,0.17,99
"dietary changes in the last 5 years Yes, because of other reasons",C0443172,Changed status,Changed status. ,0,0.271,0.0,0.0,0.0,0.0017,0.0065,-0.009,0.0,"Major dietary changes in the last 5 years_Yes, because of other reasons",1.02,67117,"Major dietary changes in the last 5 years_Yes, because of other reasons < 0.50",0.17,0.17,99
Unspecified monoarthritis,C0205370,Unspecified,Unspecified. Not stated explicitly or in detail.,0,0.253,0.0,0.0,0.0,0.0016,0.0105,-0.007,0.0004,Unspecified monoarthritis,1.36,1483,Unspecified monoarthritis < -2.60,0.21,0.21,99
Unspecified monoarthritis,C0158026,Monoarthritis,Monoarthritis. ,0,0.957,0.0,0.0,0.0,0.0016,0.0105,-0.007,0.0004,Unspecified monoarthritis,1.36,1483,Unspecified monoarthritis < -2.60,0.21,0.21,2
Gastritis and duodenitis,C0017152,Gastritis,"Gastritis. Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.",0,0.733,0.0,0.0,0.0,0.0015,0.2051,0.008,0.0004,Gastritis and duodenitis,1.27,2228,0.49 <= Gastritis and duodenitis < 4.60,0.34,0.34,2
Gastritis and duodenitis,C0013298,Duodenitis,"Duodenitis. Inflammation of the DUODENUM section of the small intestine (INTESTINE, SMALL). Erosive duodenitis may cause bleeding in the UPPER GI TRACT and PEPTIC ULCER.",0,0.746,0.0,0.0,0.0,0.0015,0.2051,0.008,0.0004,Gastritis and duodenitis,1.27,2228,0.49 <= Gastritis and duodenitis < 4.60,0.34,0.34,2
Gastritis and duodenitis,C1522057,Acute Enteritis of the Mouse Intestinal Tract,Acute Enteritis of the Mouse Intestinal Tract. ,0,0.499,0.0,0.0,0.0,0.0015,0.2051,0.008,0.0004,Gastritis and duodenitis,1.27,2228,0.49 <= Gastritis and duodenitis < 4.60,0.34,0.34,2
Other tests,C0683443,tests and testing,tests and testing. ,0,0.78,0.0,1.0,0.5,0.0013,0.0115,-0.012,0.0004,Other tests,1.01,88080,-2.40 <= Other tests < 0.10,0.1,0.12,2
M54.56 - Low back pain (Lumbar region),C0024031,Low Back Pain,"Low Back Pain. Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.",0,0.463,0.0,0.0,0.0,0.0013,0.0004,0.012,0.0002,M54.56 - Low back pain (Lumbar region),1.0,91086,-17.00 <= M54.56 - Low back pain (Lumbar region) < 0.75,0.05,0.05,2
M54.56 - Low back pain (Lumbar region),C0024090,Lumbar Region,Lumbar Region. The region of the spine below the ribs and above the hipbones.,0,0.515,0.0,0.0,0.0,0.0013,0.0004,0.012,0.0002,M54.56 - Low back pain (Lumbar region),1.0,91086,-17.00 <= M54.56 - Low back pain (Lumbar region) < 0.75,0.05,0.05,2
Other mental disorder,C0004936,Mental disorders,"Mental disorders. Psychiatric illness or diseases manifested by breakdowns in the adaptational process expressed primarily as abnormalities of thought, feeling, and behavior producing either distress or impairment of function.",0,0.636,0.0,0.0,0.0,0.0013,0.3083,-0.0,0.0003,Other mental disorder,1.26,1240,-3.30 <= Other mental disorder < -2.20,0.13,0.2,2
Other mental disorder,C0033975,Psychotic Disorders,"Psychotic Disorders. Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)",0,0.491,0.0,0.0,0.0,0.0013,0.3083,-0.0,0.0003,Other mental disorder,1.26,1240,-3.30 <= Other mental disorder < -2.20,0.13,0.2,2
Osteoarthrosis NOS,C0029408,Degenerative polyarthritis,"Degenerative polyarthritis. A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.",0,0.79,0.0,0.0,0.0,0.0013,0.3672,0.005,0.0003,Osteoarthrosis NOS,0.99,89700,-2.00 <= Osteoarthrosis NOS < 0.40,0.27,0.38,2
Osteoarthrosis NOS,C3887876,OSTEOARTHRITIS SUSCEPTIBILITY 1,OSTEOARTHRITIS SUSCEPTIBILITY 1. ,0,0.552,0.0,0.0,0.0,0.0013,0.3672,0.005,0.0003,Osteoarthrosis NOS,0.99,89700,-2.00 <= Osteoarthrosis NOS < 0.40,0.27,0.38,99
Circulatory disease NEC,C0135615,Proprotein Convertase 1,Proprotein Convertase 1. A CALCIUM-dependent endopeptidase that has specificity for cleavage at ARGININE that is near paired basic residues. It cleaves a variety of prohormones including PRO-OPIOMELANOCORTIN; PRORENIN; proenkephalins; prodynorphin; prosomatostatin; and PROINSULIN.,0,0.161,0.0,0.0,0.0,0.0013,0.039,-0.002,0.0007,Circulatory disease NEC,1.39,1979,-4.80 <= Circulatory disease NEC < -0.20,0.1,0.1,2
Angina pectoris,C0002962,Angina Pectoris,"Angina Pectoris. The symptom of paroxysmal pain consequent to MYOCARDIAL ISCHEMIA usually of distinctive character, location and radiation. It is thought to be provoked by a transient stressful situation during which the oxygen requirements of the MYOCARDIUM exceed that supplied by the CORONARY CIRCULATION.",0,0.784,0.0,0.0,0.0,0.0013,0.0441,-0.003,0.0011,Angina pectoris,1.54,1582,Angina pectoris < -3.20,0.1,0.1,2
Z87.4 - Personal history of diseases of the genito-urinary system,C0424945,Social and personal history,Social and personal history. ,0,0.173,0.0,1.0,0.3,0.0012,0.7627,0.003,0.0002,Z87.4 - Personal history of diseases of the genito-urinary system,0.99,89488,-2.00 <= Z87.4 - Personal history of diseases of the genito-urinary system < 0.02,0.04,0.04,99
Z87.4 - Personal history of diseases of the genito-urinary system,C0042066,Genitourinary system,"Genitourinary system. All the organs involved in reproduction and the formation and release of URINE. It includes the kidneys, ureters, BLADDER; URETHRA, and the organs of reproduction - ovaries, UTERUS; FALLOPIAN TUBES; VAGINA; and CLITORIS in women and the testes; SEMINAL VESICLES; PROSTATE; seminal ducts; and PENIS in men.",0,0.47,0.0,1.0,0.3,0.0012,0.7627,0.003,0.0002,Z87.4 - Personal history of diseases of the genito-urinary system,0.99,89488,-2.00 <= Z87.4 - Personal history of diseases of the genito-urinary system < 0.02,0.04,0.04,2
"dietary changes in the last 5 years Yes, because of illness",C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.297,0.0,0.0,0.0,0.0012,0.0,0.054,0.0013,"Major dietary changes in the last 5 years_Yes, because of illness",1.37,14262,"Major dietary changes in the last 5 years_Yes, because of illness >= 0.50",0.13,0.13,99
"dietary changes in the last 5 years Yes, because of illness",C0443172,Changed status,Changed status. ,0,0.271,0.0,0.0,0.0,0.0012,0.0,0.054,0.0013,"Major dietary changes in the last 5 years_Yes, because of illness",1.37,14262,"Major dietary changes in the last 5 years_Yes, because of illness >= 0.50",0.13,0.13,99
M47.82 - Other spondylosis (Cervical region),C0556956,Cervical region (surface region of back),Cervical region (surface region of back). ,0,0.414,0.0,0.0,0.0,0.0011,0.1002,-0.005,0.0002,M47.82 - Other spondylosis (Cervical region),1.0,90852,-0.73 <= M47.82 - Other spondylosis (Cervical region) < 0.34,0.18,0.19,99
M47.82 - Other spondylosis (Cervical region),C0920882,Region of neck (body structure),"Region of neck (body structure). subdivision of cardinal body part, each instance of which is a regional part of some neck. Examples: front of neck, back of neck, throat.",0,0.315,0.0,0.0,0.0,0.0011,0.1002,-0.005,0.0002,M47.82 - Other spondylosis (Cervical region),1.0,90852,-0.73 <= M47.82 - Other spondylosis (Cervical region) < 0.34,0.18,0.19,2
Average Diameter for VLDL Particles,C1301886,Diameter (qualifier value),Diameter (qualifier value). The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,0,0.421,0.0,0.0,0.0,0.0011,0.0,0.031,0.0285,Average Diameter for VLDL Particles,1.87,986,3.30 <= Average Diameter for VLDL Particles < 5.90,-0.02,0.02,2
W19.9 - Unspecified place,C0205370,Unspecified,Unspecified. Not stated explicitly or in detail.,0,0.377,0.0,0.0,0.0,0.0011,0.4607,-0.002,0.0001,W19.9 - Unspecified place,1.0,90852,-7.00 <= W19.9 - Unspecified place < 0.04,-0.02,-0.02,99
Apolipoprotein B,C1412471,APOB gene,APOB gene. This gene plays a role in lipid transport.,0,0.727,0.0,1.0,0.3,0.001,0.0,-0.038,0.1289,Apolipoprotein B,1.37,4622,Apolipoprotein B < -1.70,0.2,0.2,2
Apolipoprotein B,C0003591,Apolipoproteins,Apolipoproteins. Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES.,0,0.713,0.0,1.0,0.3,0.001,0.0,-0.038,0.1289,Apolipoprotein B,1.37,4622,Apolipoprotein B < -1.70,0.2,0.2,2
M25.56 - Pain in joint (Lower leg),C1549543,Administration Method - Pain,Administration Method - Pain. ,0,0.221,0.0,0.0,0.0,0.001,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,0.02,0.02,99
M25.56 - Pain in joint (Lower leg),C1140621,Leg,Leg. The inferior part of the lower extremity between the KNEE and the ANKLE.,0,0.278,0.0,0.0,0.0,0.001,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,0.02,0.02,2
M25.56 - Pain in joint (Lower leg),C4299093,Lower extremity>Lower leg,Lower extremity>Lower leg. ,0,0.308,0.0,0.0,0.0,0.001,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,0.02,0.02,99
Pneumococcal pneumonia,C0032300,Lobar Pneumonia,Lobar Pneumonia. ,0,0.591,0.0,0.0,0.0,0.001,0.1003,-0.004,0.0002,Pneumococcal pneumonia,1.0,90494,-4.70 <= Pneumococcal pneumonia < 5.00,0.12,0.12,2
Pneumococcal pneumonia,C0155862,Streptococcal pneumonia,Streptococcal pneumonia. A febrile disease caused by STREPTOCOCCUS PNEUMONIAE.,0,0.793,0.0,0.0,0.0,0.001,0.1003,-0.004,0.0002,Pneumococcal pneumonia,1.0,90494,-4.70 <= Pneumococcal pneumonia < 5.00,0.12,0.12,2
Overall health rating Fair,C1547189,Fair Language Proficiency,Fair Language Proficiency. ,0,0.398,0.0,0.0,0.0,0.001,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.02,-0.02,99
Overall health rating Fair,C1548785,Fair Specimen Quality,Fair Specimen Quality. ,0,0.395,0.0,0.0,0.0,0.001,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.02,-0.02,99
Overall health rating Fair,C2911689,Fair (qualifier),Fair (qualifier). Having no exceptional quality or ability.,0,0.526,0.0,0.0,0.0,0.001,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.02,-0.02,99
Average Diameter for LDL Particles,C1301886,Diameter (qualifier value),Diameter (qualifier value). The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,0,0.466,0.0,0.0,0.0,0.0009,0.0,-0.027,0.0039,Average Diameter for LDL Particles,1.21,7036,-5.50 <= Average Diameter for LDL Particles < -0.75,0.01,0.11,2
Average Diameter for HDL Particles,C1301886,Diameter (qualifier value),Diameter (qualifier value). The length of a straight line passing through the center of a circle or sphere and connecting two points on the circumference.,0,0.455,0.0,0.0,0.0,0.0009,0.0,-0.021,0.03,Average Diameter for HDL Particles,1.15,7281,-3.00 <= Average Diameter for HDL Particles < -0.96,0.05,0.06,2
Qualifications College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,C0205163,Equal,Equal. A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something.,0,0.305,0.0,0.0,0.0,0.0009,0.0001,-0.013,0.0001,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,1.01,88450,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent < 0.50,0.04,0.04,99
Qualifications College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,C0439185,Equivalent Weight,"Equivalent Weight. A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.",0,0.279,0.0,0.0,0.0,0.0009,0.0001,-0.013,0.0001,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,1.01,88450,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent < 0.50,0.04,0.04,2
Peripheral enthesopathies and allied syndromes,C0457623,Peripheral enthesopathy,Peripheral enthesopathy. ,0,0.859,0.0,0.0,0.0,0.0009,0.1883,0.006,0.0004,Peripheral enthesopathies and allied syndromes,0.99,89222,-2.10 <= Peripheral enthesopathies and allied syndromes < 0.90,0.16,0.21,2
Concentration of Large HDL Particles,C0549177,Large,"Large. Of considerable or relatively great size, extent, or capacity.",0,0.245,0.0,0.0,0.0,0.0008,0.0,-0.025,0.0679,Concentration of Large HDL Particles,1.47,954,-3.10 <= Concentration of Large HDL Particles < -2.30,0.07,0.15,2
Concentration of Large HDL Particles,C1416798,LARGE1 gene,LARGE1 gene. ,0,0.293,0.0,0.0,0.0,0.0008,0.0,-0.025,0.0679,Concentration of Large HDL Particles,1.47,954,-3.10 <= Concentration of Large HDL Particles < -2.30,0.07,0.15,2
depression,C0011570,Mental Depression,Mental Depression. Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.,0,0.588,0.0,1.0,0.3,0.0008,0.0536,-0.006,0.0,"Non-cancer illness code, self-reported | Array 1__depression",1.0,90295,"Non-cancer illness code, self-reported | Array 1__depression < 0.12",-0.02,-0.02,2
depression,C0011581,Depressive disorder,Depressive disorder. An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.,0,0.678,0.0,1.0,0.3,0.0008,0.0536,-0.006,0.0,"Non-cancer illness code, self-reported | Array 1__depression",1.0,90295,"Non-cancer illness code, self-reported | Array 1__depression < 0.12",-0.02,-0.02,2
Alcohol-related disorders,C0236664,Alcohol Related Disorders,Alcohol Related Disorders. Disorders related to or resulting from abuse or misuse of alcohol.,0,0.961,0.0,0.0,0.0,0.0008,0.0049,0.009,0.0007,Alcohol-related disorders,0.99,89420,-0.04 <= Alcohol-related disorders < 0.44,0.24,0.28,2
Z96.6 - Presence of orthopaedic joint implants,C3854307,Presence (property),Presence (property). ,0,0.242,0.0,0.0,0.0,0.0008,0.0006,-0.007,0.0003,Z96.6 - Presence of orthopaedic joint implants,1.33,1458,-6.30 <= Z96.6 - Presence of orthopaedic joint implants < -0.35,0.09,0.2,99
Z96.6 - Presence of orthopaedic joint implants,C0021102,Implants,Implants. A prosthesis placed permanently in tissue.,0,0.45,0.0,0.0,0.0,0.0008,0.0006,-0.007,0.0003,Z96.6 - Presence of orthopaedic joint implants,1.33,1458,-6.30 <= Z96.6 - Presence of orthopaedic joint implants < -0.35,0.09,0.2,2
kidney,C0227665,Both kidneys,Both kidneys. ,0,0.657,0.0,1.0,0.3,0.0007,0.0,0.029,0.0004,"Non-cancer illness code, self-reported | Array 3__kidney",0.99,91272,"Non-cancer illness code, self-reported | Array 3__kidney < 0.11",0.21,0.21,2
kidney,C0203408,Echography of kidney,Echography of kidney. The use of ultrasound to image the kidney.,0,0.508,0.0,1.0,0.3,0.0007,0.0,0.029,0.0004,"Non-cancer illness code, self-reported | Array 3__kidney",0.99,91272,"Non-cancer illness code, self-reported | Array 3__kidney < 0.11",0.21,0.21,2
Other and unspecified disc disorder,C0012619,disc disorder,disc disorder. ,0,0.96,0.0,0.0,0.0,0.0006,0.1101,0.006,0.0003,Other and unspecified disc disorder,1.0,90789,-7.00 <= Other and unspecified disc disorder < 3.60,0.21,0.31,2
Hypertensive chronic kidney disease,C3695318,Chronic kidney disease due to hypertension,Chronic kidney disease due to hypertension. Longstanding kidney disease as a complication of hypertension.,0,0.92,0.0,0.0,0.0,0.0006,0.0077,0.014,0.002,Hypertensive chronic kidney disease,0.98,90787,-0.60 <= Hypertensive chronic kidney disease < 0.03,0.07,0.07,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0008387,Cholesterol Esters,Cholesterol Esters. Fatty acid esters of cholesterol which constitute about two-thirds of the cholesterol in the plasma. The accumulation of cholesterol esters in the arterial intima is a characteristic feature of atherosclerosis.,0,0.392,0.0,3.0,0.4,0.0006,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",0.18,0.18,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0005823,Blood Pressure,Blood Pressure. PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.,0,0.34,0.0,3.0,0.4,0.0006,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",0.18,0.18,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0005824,Blood pressure determination,Blood pressure determination. Techniques used for measuring BLOOD PRESSURE.,0,0.293,0.0,3.0,0.4,0.0006,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",0.18,0.18,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C1271104,Blood pressure finding,Blood pressure finding. A test result that reports the diastolic and systolic pressure of the blood.,0,0.295,0.0,3.0,0.4,0.0006,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",0.18,0.18,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",C0362046,Prediabetes syndrome,"Prediabetes syndrome. The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).",0,0.175,0.0,3.0,0.4,0.0006,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",0.18,0.18,2
Osteoarthritis; localized,C0029408,Degenerative polyarthritis,"Degenerative polyarthritis. A progressive, degenerative joint disease, the most common form of arthritis, especially in older persons. The disease is thought to result not from the aging process but from biochemical changes and biomechanical stresses affecting articular cartilage. In the foreign literature it is often called osteoarthrosis deformans.",0,0.621,0.0,0.0,0.0,0.0006,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,0.22,0.32,2
Osteoarthritis; localized,C0949690,Spondylarthritis,"Spondylarthritis. Inflammation of the joints of the SPINE, the intervertebral articulations.",0,0.487,0.0,0.0,0.0,0.0006,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,0.22,0.32,2
Osteoarthritis; localized,C2350242,"Osteoarthritis, Spine","Osteoarthritis, Spine. A degenerative joint disease involving the SPINE. It is characterized by progressive deterioration of the spinal articular cartilage (CARTILAGE, ARTICULAR), usually with hardening of the subchondral bone and outgrowth of bone spurs (OSTEOPHYTE).",0,0.494,0.0,0.0,0.0,0.0006,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,0.22,0.32,99
Osteoarthritis; localized,C0392752,Localized,Localized. Being confined or restricted to a particular location. [HPO:probinson],0,0.415,0.0,0.0,0.0,0.0006,0.018,-0.004,0.0002,Osteoarthritis; localized,1.12,947,-5.50 <= Osteoarthritis; localized < -0.13,0.22,0.32,3
M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,C0024090,Lumbar Region,Lumbar Region. The region of the spine below the ribs and above the hipbones.,0,0.398,0.0,0.0,0.0,0.0006,0.0877,0.007,0.0002,M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,1.0,90946,-9.00 <= M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy < 4.40,0.17,0.18,2
M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,C0700594,Radiculopathy,"Radiculopathy. Disease involving a spinal nerve root (see SPINAL NERVE ROOTS) which may result from compression related to INTERVERTEBRAL DISK DISPLACEMENT; SPINAL CORD INJURIES; SPINAL DISEASES; and other conditions. Clinical manifestations include radicular pain, weakness, and sensory loss referable to structures innervated by the involved nerve root.",0,0.685,0.0,0.0,0.0,0.0006,0.0877,0.007,0.0002,M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,1.0,90946,-9.00 <= M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy < 4.40,0.17,0.18,2
"Other diseases of respiratory system, NEC",C0029896,Otorhinolaryngologic Diseases,"Otorhinolaryngologic Diseases. Pathological processes of the ear, the nose, and the throat, also known as the ENT diseases.",0,0.353,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.22,0.31,2
"Other diseases of respiratory system, NEC",C0035237,Respiratory System,"Respiratory System. The tubular and cavernous organs and structures, by means of which pulmonary ventilation and gas exchange between ambient air and the blood are brought about.",0,0.437,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.22,0.31,2
"Other diseases of respiratory system, NEC",C0282686,Respiratory System Agents,Respiratory System Agents. Drugs used for their effects on the respiratory system.,0,0.471,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.22,0.31,2
"Other diseases of respiratory system, NEC",C3541375,RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS,RESPIRATORY SYSTEM DIAGNOSTIC RADIOPHARMACEUTICALS. ,0,0.446,0.0,0.0,0.0,0.0006,0.0058,-0.006,0.0003,"Other diseases of respiratory system, NEC",1.01,1693,"Other diseases of respiratory system, NEC >= 2.10",0.22,0.31,99
pulmonary,C0024109,Lung,Lung. Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.,0,0.576,0.0,0.0,0.0,0.0006,0.0,0.032,0.0004,"Non-cancer illness code, self-reported | Array 2__pulmonary",0.99,91295,"Non-cancer illness code, self-reported | Array 2__pulmonary < 0.22",0.14,0.14,2
pulmonary,C2709248,Pulmonary (qualifier value),"Pulmonary (qualifier value). Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.",0,0.603,0.0,0.0,0.0,0.0006,0.0,0.032,0.0004,"Non-cancer illness code, self-reported | Array 2__pulmonary",0.99,91295,"Non-cancer illness code, self-reported | Array 2__pulmonary < 0.22",0.14,0.14,99
Umbilical hernia,C1306503,Congenital exomphalos,"Congenital exomphalos. A HERNIA due to an imperfect closure or weakness of the umbilical ring. It appears as a skin-covered protrusion at the UMBILICUS during crying, coughing, or straining. The hernia generally consists of OMENTUM or SMALL INTESTINE. The vast majority of umbilical hernias are congenital but can be acquired due to severe abdominal distention.",0,0.846,0.0,1.0,0.5,0.0006,0.0074,-0.005,0.0002,Umbilical hernia,1.0,89838,-1.20 <= Umbilical hernia < 0.56,0.16,0.16,2
Epistaxis or throat hemorrhage,C0014591,Epistaxis,Epistaxis. Bleeding from the nose.,0,0.776,0.0,0.0,0.0,0.0005,0.0024,-0.005,0.0004,Epistaxis or throat hemorrhage,0.99,90943,-0.65 <= Epistaxis or throat hemorrhage < 8.90,0.09,0.09,2
Epistaxis or throat hemorrhage,C0576995,Pharyngeal Hemorrhage,Pharyngeal Hemorrhage. Bleeding originating from the pharynx.,0,0.673,0.0,0.0,0.0,0.0005,0.0024,-0.005,0.0004,Epistaxis or throat hemorrhage,0.99,90943,-0.65 <= Epistaxis or throat hemorrhage < 8.90,0.09,0.09,99
Phlebitis and thrombophlebitis of lower extremities,C0031542,Phlebitis,"Phlebitis. Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS).",0,0.801,0.0,0.0,0.0,0.0005,0.079,-0.004,0.0003,Phlebitis and thrombophlebitis of lower extremities,1.0,90658,-2.20 <= Phlebitis and thrombophlebitis of lower extremities < 6.70,0.11,0.16,2
Phlebitis and thrombophlebitis of lower extremities,C0040046,Thrombophlebitis,Thrombophlebitis. Inflammation of a vein associated with a blood clot (THROMBUS).,0,0.717,0.0,0.0,0.0,0.0005,0.079,-0.004,0.0003,Phlebitis and thrombophlebitis of lower extremities,1.0,90658,-2.20 <= Phlebitis and thrombophlebitis of lower extremities < 6.70,0.11,0.16,2
Phlebitis and thrombophlebitis of lower extremities,C0023216,Lower Extremity,"Lower Extremity. The region of the lower limb in animals, extending from the gluteal region to the FOOT, and including the BUTTOCKS; HIP; and LEG.",0,0.606,0.0,0.0,0.0,0.0005,0.079,-0.004,0.0003,Phlebitis and thrombophlebitis of lower extremities,1.0,90658,-2.20 <= Phlebitis and thrombophlebitis of lower extremities < 6.70,0.11,0.16,2
Phlebitis and thrombophlebitis of lower extremities,C0448188,Bone structure of lower limb,Bone structure of lower limb. A bone of the leg (lower extremity).,0,0.548,0.0,0.0,0.0,0.0005,0.079,-0.004,0.0003,Phlebitis and thrombophlebitis of lower extremities,1.0,90658,-2.20 <= Phlebitis and thrombophlebitis of lower extremities < 6.70,0.11,0.16,2
myocardial infarction,C0027051,Myocardial Infarction,Myocardial Infarction. NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).,0,0.756,0.0,0.0,0.0,0.0005,0.0,0.044,0.0008,"Non-cancer illness code, self-reported | Array 0__myocardial infarction",1.57,4617,"Non-cancer illness code, self-reported | Array 0__myocardial infarction >= 0.19",0.1,0.1,2
myocardial infarction,C0155668,Old myocardial infarction,"Old myocardial infarction. Documented history of previous myocardial infarction (MI), typically with objective evidence via positive biomarkers of myocardial necrosis.",0,0.713,0.0,0.0,0.0,0.0005,0.0,0.044,0.0008,"Non-cancer illness code, self-reported | Array 0__myocardial infarction",1.57,4617,"Non-cancer illness code, self-reported | Array 0__myocardial infarction >= 0.19",0.1,0.1,2
asthma,C0004096,Asthma,"Asthma. A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).",0,0.508,0.0,0.0,0.0,0.0005,0.0,0.026,0.0003,"Non-cancer illness code, self-reported | Array 1__asthma",1.36,4004,"Non-cancer illness code, self-reported | Array 1__asthma >= 0.50",0.09,0.16,2
Abnormal findings examination of lungs,C0205161,Abnormal,"Abnormal. Deviating in any way from the state, position, structure, condition, behavior, or rule which is considered a norm.",0,0.2,0.0,0.0,0.0,0.0005,0.0845,-0.002,0.0002,Abnormal findings examination of lungs,1.0,91075,-3.20 <= Abnormal findings examination of lungs < 8.40,0.2,0.29,2
Abnormal findings examination of lungs,C2607943,findings aspects,findings aspects. ,0,0.352,0.0,0.0,0.0,0.0005,0.0845,-0.002,0.0002,Abnormal findings examination of lungs,1.0,91075,-3.20 <= Abnormal findings examination of lungs < 8.40,0.2,0.29,99
Abnormal findings examination of lungs,C0582103,Medical Examination,"Medical Examination. An appraisal or evaluation of a patient's condition by a clinician that is based on a physical exam, medical history, and the patient's account of symptoms.",0,0.158,0.0,0.0,0.0,0.0005,0.0845,-0.002,0.0002,Abnormal findings examination of lungs,1.0,91075,-3.20 <= Abnormal findings examination of lungs < 8.40,0.2,0.29,2
Abnormal findings examination of lungs,C4321457,Examination,Examination. A formal or careful inspection of an object or subject.,0,0.216,0.0,0.0,0.0,0.0005,0.0845,-0.002,0.0002,Abnormal findings examination of lungs,1.0,91075,-3.20 <= Abnormal findings examination of lungs < 8.40,0.2,0.29,99
Abnormal findings examination of lungs,C0024109,Lung,Lung. Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood.,0,0.485,0.0,0.0,0.0,0.0005,0.0845,-0.002,0.0002,Abnormal findings examination of lungs,1.0,91075,-3.20 <= Abnormal findings examination of lungs < 8.40,0.2,0.29,2
Congenital anomalies of great vessels,C0000768,Congenital Abnormality,Congenital Abnormality. Malformations of organs or body parts during development in utero.,0,0.48,0.0,0.0,0.0,0.0005,0.1697,0.005,0.0002,Congenital anomalies of great vessels,1.0,90650,-2.30 <= Congenital anomalies of great vessels < 0.41,0.03,0.03,2
Congenital anomalies of great vessels,C0266292,Congenital anomaly of the kidney,Congenital anomaly of the kidney. An abnormality of the kidney. [HPO:probinson],0,0.329,0.0,0.0,0.0,0.0005,0.1697,0.005,0.0002,Congenital anomalies of great vessels,1.0,90650,-2.30 <= Congenital anomalies of great vessels < 0.41,0.03,0.03,2
Congenital anomalies of great vessels,C0225991,Structure of great blood vessel (organ),"Structure of great blood vessel (organ). Any of the major arteries or veins attached to the cardiac atria or ventricles. This includes the aorta, superior and inferior vena cava and the pulmonary arteries and veins.",0,0.658,0.0,0.0,0.0,0.0005,0.1697,0.005,0.0002,Congenital anomalies of great vessels,1.0,90650,-2.30 <= Congenital anomalies of great vessels < 0.41,0.03,0.03,2
medication cialis 10mg,C0967376,Cialis,Cialis. ,0,0.588,0.0,0.0,0.0,0.0004,0.1024,0.005,0.0,Treatment/medication code | Array 0__cialis 10mg,1.0,91536,Treatment/medication code | Array 0__cialis 10mg < 0.28,-0.05,-0.05,2
medication 100mg capsule,C0006935,capsule (pharmacologic),capsule (pharmacologic). Hard or soft soluble containers used for the oral administration of medicine.,0,0.294,0.0,0.0,0.0,0.0004,0.004,0.009,0.0,Treatment/medication code | Array 0__100mg capsule,1.0,91540,Treatment/medication code | Array 0__100mg capsule < 0.25,-0.0,-0.0,2
medication ibuprofen,C0020740,ibuprofen,"ibuprofen. A non-steroidal anti-inflammatory agent with analgesic, antipyretic, and anti-inflammatory properties",0,0.906,0.0,0.0,0.0,0.0004,0.0,-0.026,0.0004,Treatment/medication code | Array 0__ibuprofen,1.02,87653,Treatment/medication code | Array 0__ibuprofen < 0.57,0.15,0.15,2
Rheumatoid arthritis,C0038013,Ankylosing spondylitis,"Ankylosing spondylitis. A chronic inflammatory condition affecting the axial joints, such as the SACROILIAC JOINT and other intervertebral or costovertebral joints. It occurs predominantly in young males and is characterized by pain and stiffness of joints (ANKYLOSIS) with inflammation at tendon insertions.",0,0.514,0.0,1.0,0.5,0.0004,0.15,0.004,0.0002,Rheumatoid arthritis,1.0,90983,-3.10 <= Rheumatoid arthritis < 3.60,0.19,0.2,2
Home area population density - urban or rural Scotland - Accessible Small Town,C0178587,density,density. The amount of something per unit size.,0,0.234,0.0,0.0,0.0,0.0004,0.0288,-0.007,0.0,Home area population density - urban or rural_Scotland - Accessible Small Town,1.0,91323,Home area population density - urban or rural_Scotland - Accessible Small Town < 0.50,-0.12,-0.12,2
Home area population density - urban or rural Scotland - Accessible Small Town,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.34,0.0,0.0,0.0,0.0004,0.0288,-0.007,0.0,Home area population density - urban or rural_Scotland - Accessible Small Town,1.0,91323,Home area population density - urban or rural_Scotland - Accessible Small Town < 0.50,-0.12,-0.12,3
Home area population density - urban or rural Scotland - Accessible Small Town,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.294,0.0,0.0,0.0,0.0004,0.0288,-0.007,0.0,Home area population density - urban or rural_Scotland - Accessible Small Town,1.0,91323,Home area population density - urban or rural_Scotland - Accessible Small Town < 0.50,-0.12,-0.12,99
pulmonary embolism,C0034065,Pulmonary Embolism,Pulmonary Embolism. Blocking of the PULMONARY ARTERY or one of its branches by an EMBOLUS.,0,0.886,0.0,0.0,0.0,0.0003,0.0,0.026,0.0002,"Non-cancer illness code, self-reported | Array 2__pulmonary embolism",1.0,91331,"Non-cancer illness code, self-reported | Array 2__pulmonary embolism < 0.23",0.16,0.16,2
pulmonary embolism,C0340537,Pulmonary fat embolism,"Pulmonary fat embolism. The release of fat globules into the venous circulation, thereby blocking blood circulation to the lung. [ORCID:0000-0001-5208-3432, PMID:24468004]",0,0.597,0.0,0.0,0.0,0.0003,0.0,0.026,0.0002,"Non-cancer illness code, self-reported | Array 2__pulmonary embolism",1.0,91331,"Non-cancer illness code, self-reported | Array 2__pulmonary embolism < 0.23",0.16,0.16,2
pulmonary embolism,C2882221,Acute pulmonary embolism,Acute pulmonary embolism. An acute embolism to the pulmonary vasculature.,0,0.811,0.0,0.0,0.0,0.0003,0.0,0.026,0.0002,"Non-cancer illness code, self-reported | Array 2__pulmonary embolism",1.0,91331,"Non-cancer illness code, self-reported | Array 2__pulmonary embolism < 0.23",0.16,0.16,2
heart,C4037974,Chest>Heart,Chest>Heart. ,0,0.715,0.0,1.0,0.5,0.0003,0.0,0.043,0.0009,"Non-cancer illness code, self-reported | Array 0__heart",1.57,4617,"0.36 <= Non-cancer illness code, self-reported | Array 0__heart < 0.38",0.08,0.08,99
Qualifications College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,C0205163,Equal,Equal. A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something.,0,0.244,0.0,0.0,0.0,0.0003,0.084,-0.006,0.0,Qualifications_College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,91267,Qualifications_College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.08,-0.08,99
Qualifications College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,C0439185,Equivalent Weight,"Equivalent Weight. A unit of relative amount of a substance that combines with or displaces 8.0 grams of oxygen or 1.008 gram of hydrogen. The unit is usually expressed in grams and is equal to the amount of substance that gains or loses one mole of electrons in a redox reaction, or to the amount of substances that releases or accepts one mole of hydrogen ions in a neutralization reaction; or to the amount of electrolyte that carries one mole of positive or negative charge. This is a large unit and measurements are more often done in its derivatives, e.g. in milliequivalents.",0,0.258,0.0,0.0,0.0,0.0003,0.084,-0.006,0.0,Qualifications_College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,91267,Qualifications_College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.08,-0.08,2
Qualifications NVQ or HND or HNC or equivalent,C0205163,Equal,Equal. A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something.,0,0.229,0.0,0.0,0.0,0.0003,0.0026,0.01,0.0,Qualifications_NVQ or HND or HNC or equivalent,1.1,7423,Qualifications_NVQ or HND or HNC or equivalent >= 0.50,-0.07,-0.07,99
Dental caries,C0011334,Dental caries,"Dental caries. Localized destruction of the tooth surface initiated by decalcification of the enamel followed by enzymatic lysis of organic structures and leading to cavity formation. If left unchecked, the cavity may penetrate the enamel and dentin and reach the pulp.",0,0.784,0.0,0.0,0.0,0.0003,0.0656,-0.004,0.0002,Dental caries,1.0,90780,-1.90 <= Dental caries < 3.40,0.14,0.24,2
Z03.8 - Observation for other suspected diseases and conditions,C0302523,Observation in research,"Observation in research. The act of regarding attentively and studying facts and occurrences, gathering data through analyzing, measuring, and drawing conclusions, with the purpose of applying the observed information to theoretical assumptions. Observation as a scientific method in the acquisition of knowledge began in classical antiquity; in modern science and medicine its greatest application is facilitated by modern technology. Observation is one of the components of the research process.",0,0.22,0.0,0.0,0.0,0.0003,0.0591,0.004,0.0002,Z03.8 - Observation for other suspected diseases and conditions,1.0,89673,-0.22 <= Z03.8 - Observation for other suspected diseases and conditions < 0.38,0.14,0.14,2
Z03.8 - Observation for other suspected diseases and conditions,C0700325,Patient observation,"Patient observation. Clinical management approach wherein immediate therapy is not provided but there is a period of observation during which periodic tests monitor patient and the progression of the illness. (Driffield T, Smith PC Med Decis Making. 2007 Mar-Apr;27(2):178-88)",0,0.179,0.0,0.0,0.0,0.0003,0.0591,0.004,0.0002,Z03.8 - Observation for other suspected diseases and conditions,1.0,89673,-0.22 <= Z03.8 - Observation for other suspected diseases and conditions < 0.38,0.14,0.14,2
Z03.8 - Observation for other suspected diseases and conditions,C0332147,Suspected diagnosis,Suspected diagnosis. ,0,0.591,0.0,0.0,0.0,0.0003,0.0591,0.004,0.0002,Z03.8 - Observation for other suspected diseases and conditions,1.0,89673,-0.22 <= Z03.8 - Observation for other suspected diseases and conditions < 0.38,0.14,0.14,99
Altered mental status,C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.394,0.0,0.0,0.0,0.0003,0.1685,-0.005,0.0001,Altered mental status,1.0,90929,-13.00 <= Altered mental status < 2.40,0.03,0.03,99
Altered mental status,C0278060,Mental state,Mental state. ,0,0.651,0.0,0.0,0.0,0.0003,0.1685,-0.005,0.0001,Altered mental status,1.0,90929,-13.00 <= Altered mental status < 2.40,0.03,0.03,2
Mental health conditions ever diagnosed by a professional group depression,C0011570,Mental Depression,Mental Depression. Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.,0,0.415,0.0,1.0,0.3,0.0003,0.0,-0.015,0.001,Mental health conditions ever diagnosed by a professional__group depression,1.01,87484,Mental health conditions ever diagnosed by a professional__group depression < 0.15,-0.01,-0.01,2
Mental health conditions ever diagnosed by a professional group depression,C0011581,Depressive disorder,Depressive disorder. An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.,0,0.577,0.0,1.0,0.3,0.0003,0.0,-0.015,0.001,Mental health conditions ever diagnosed by a professional__group depression,1.01,87484,Mental health conditions ever diagnosed by a professional__group depression < 0.15,-0.01,-0.01,2
dietary changes in the last 5 years Prefer not to answer,C0392747,Changing,Changing. The act of alteration or modification; changed or altered in form or character.,0,0.267,0.0,1.0,0.3,0.0003,0.013,0.008,0.0,Major dietary changes in the last 5 years_Prefer not to answer,1.0,91330,Major dietary changes in the last 5 years_Prefer not to answer < 0.50,0.06,0.06,99
dietary changes in the last 5 years Prefer not to answer,C0443172,Changed status,Changed status. ,0,0.204,0.0,1.0,0.3,0.0003,0.013,0.008,0.0,Major dietary changes in the last 5 years_Prefer not to answer,1.0,91330,Major dietary changes in the last 5 years_Prefer not to answer < 0.50,0.06,0.06,99
medication 5mg capsule,C0006935,capsule (pharmacologic),capsule (pharmacologic). Hard or soft soluble containers used for the oral administration of medicine.,0,0.225,0.0,0.0,0.0,0.0003,0.0,0.014,0.0001,Treatment/medication code | Array 0__5mg capsule,1.0,91198,Treatment/medication code | Array 0__5mg capsule < 0.41,-0.09,-0.09,2
atrial,C0018792,Heart Atrium,"Heart Atrium. The chambers of the heart, to which the BLOOD returns from the circulation.",0,0.808,0.0,0.0,0.0,0.0003,0.0,0.022,0.0002,"Non-cancer illness code, self-reported | Array 1__atrial",1.0,91151,"Non-cancer illness code, self-reported | Array 1__atrial < 0.29",0.03,0.07,2
medication amitriptyline,C0002600,amitriptyline,"amitriptyline. Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.",0,0.861,0.0,0.0,0.0,0.0003,0.1629,-0.005,0.0,Treatment/medication code | Array 0__amitriptyline,1.0,89922,Treatment/medication code | Array 0__amitriptyline < 0.13,0.11,0.11,2
Concentration of Large LDL Particles,C0549177,Large,"Large. Of considerable or relatively great size, extent, or capacity.",0,0.272,0.0,0.0,0.0,0.0003,0.0,-0.024,0.0683,Concentration of Large LDL Particles,1.16,7437,-3.50 <= Concentration of Large LDL Particles < -0.85,0.04,0.19,2
Concentration of Large LDL Particles,C1416798,LARGE1 gene,LARGE1 gene. ,0,0.282,0.0,0.0,0.0,0.0003,0.0,-0.024,0.0683,Concentration of Large LDL Particles,1.16,7437,-3.50 <= Concentration of Large LDL Particles < -0.85,0.04,0.19,2
medication amiodarone,C0002598,amiodarone,amiodarone. An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.,0,0.886,0.0,0.0,0.0,0.0003,0.0,0.018,0.0001,Treatment/medication code | Array 0__amiodarone,1.0,91432,Treatment/medication code | Array 0__amiodarone < 0.50,0.08,0.08,2
Home area population density - urban or rural Scotland - Accessible Rural,C0178587,density,density. The amount of something per unit size.,0,0.205,0.0,0.0,0.0,0.0002,0.0003,-0.012,0.0001,Home area population density - urban or rural_Scotland - Accessible Rural,1.0,91322,Home area population density - urban or rural_Scotland - Accessible Rural < 0.50,-0.1,-0.1,2
Home area population density - urban or rural Scotland - Accessible Rural,C0442529,Urban environment,"Urban environment. A delineated geographic area encompassing residential, commercial, and other non-residential urban land uses with a residential population of 50,000 or more people and a density of 1,000 people or more per square mile.",0,0.327,0.0,0.0,0.0,0.0002,0.0003,-0.012,0.0001,Home area population density - urban or rural_Scotland - Accessible Rural,1.0,91322,Home area population density - urban or rural_Scotland - Accessible Rural < 0.50,-0.1,-0.1,3
Home area population density - urban or rural Scotland - Accessible Rural,C2700386,Urban - qualifier,"Urban - qualifier. Relating to, located in, or characteristic of a city or densely populated area.",0,0.312,0.0,0.0,0.0,0.0002,0.0003,-0.012,0.0001,Home area population density - urban or rural_Scotland - Accessible Rural,1.0,91322,Home area population density - urban or rural_Scotland - Accessible Rural < 0.50,-0.1,-0.1,99
Home area population density - urban or rural Scotland - Accessible Rural,C0240919,Rural,Rural. Of or pertaining to the country as opposed to the city. (American Heritage Dictionary),0,0.45,0.0,0.0,0.0,0.0002,0.0003,-0.012,0.0001,Home area population density - urban or rural_Scotland - Accessible Rural,1.0,91322,Home area population density - urban or rural_Scotland - Accessible Rural < 0.50,-0.1,-0.1,2
myxoedema,C0027145,Myxedema,"Myxedema. A condition characterized by a dry, waxy type of swelling (EDEMA) with abnormal deposits of MUCOPOLYSACCHARIDES in the SKIN and other tissues. It is caused by a deficiency of THYROID HORMONES. The skin becomes puffy around the eyes and on the cheeks. The face is dull and expressionless with thickened nose and lips.",0,0.638,0.0,0.0,0.0,0.0002,0.1248,-0.005,0.0,"Non-cancer illness code, self-reported | Array 1__myxoedema",1.0,90531,"Non-cancer illness code, self-reported | Array 1__myxoedema < 0.29",0.07,0.07,2
failure,C0231174,Failure (biologic function),Failure (biologic function). ,0,0.826,0.0,0.0,0.0,0.0002,0.0,0.035,0.0004,"Non-cancer illness code, self-reported | Array 2__failure",1.0,91470,"Non-cancer illness code, self-reported | Array 2__failure < 0.18",0.02,0.02,99
failure,C0680095,Personal failure,Personal failure. ,0,0.59,0.0,0.0,0.0,0.0002,0.0,0.035,0.0004,"Non-cancer illness code, self-reported | Array 2__failure",1.0,91470,"Non-cancer illness code, self-reported | Array 2__failure < 0.18",0.02,0.02,99
chronic bronchitis,C0008677,"Bronchitis, Chronic","Bronchitis, Chronic. A subcategory of CHRONIC OBSTRUCTIVE PULMONARY DISEASE. The disease is characterized by hypersecretion of mucus accompanied by a chronic (more than 3 months in 2 consecutive years) productive cough. Infectious agents are a major cause of chronic bronchitis.",0,0.849,0.0,0.0,0.0,0.0002,0.0,0.014,0.0001,"Non-cancer illness code, self-reported | Array 1__chronic bronchitis",1.0,90908,"Non-cancer illness code, self-reported | Array 1__chronic bronchitis < 0.23",0.25,0.29,2
hernia,C0019270,Hernia,"Hernia. Protrusion of tissue, structure, or part of an organ through the bone, muscular tissue, or the membrane by which it is normally contained. Hernia may involve tissues such as the ABDOMINAL WALL or the respiratory DIAPHRAGM. Hernias may be internal, external, congenital, or acquired.",0,0.866,0.0,0.0,0.0,0.0002,0.0006,0.012,0.0001,"Non-cancer illness code, self-reported | Array 3__hernia",1.0,91056,"Non-cancer illness code, self-reported | Array 3__hernia < 0.24",0.32,0.32,2
polycystic,C3273362,Polycystic,Polycystic. The presence of multiple cysts in one or several organs.,0,0.83,0.0,0.0,0.0,0.0002,0.0,0.026,0.0002,"Non-cancer illness code, self-reported | Array 1__polycystic",1.0,91540,"Non-cancer illness code, self-reported | Array 1__polycystic < 0.31",0.29,0.41,99
problem,C0033213,Problem,"Problem. A difficulty, disorder, or condition needing resolution.",0,0.726,0.0,0.0,0.0,0.0002,0.0,0.021,0.0002,"Non-cancer illness code, self-reported | Array 6__problem",1.0,91396,"Non-cancer illness code, self-reported | Array 6__problem < 0.16",0.12,0.21,2
Occlusion of cerebral arteries,C0011382,Dental Occlusion,"Dental Occlusion. The relationship of all the components of the masticatory system in normal function. It has special reference to the position and contact of the maxillary and mandibular teeth for the highest efficiency during the excursive movements of the jaw that are essential for mastication. (From Jablonski, Dictionary of Dentistry, 1992, p556, p472)",0,0.201,0.0,2.0,0.4,0.0002,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,0.08,0.21,2
Occlusion of cerebral arteries,C0007770,Structure of cerebral artery,Structure of cerebral artery. The arterial blood vessels supplying the CEREBRUM.,0,0.751,0.0,2.0,0.4,0.0002,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,0.08,0.21,2
Occlusion of cerebral arteries,C4266573,Head>Cerebral arteries,Head>Cerebral arteries. ,0,0.743,0.0,2.0,0.4,0.0002,0.0176,-0.005,0.0002,Occlusion of cerebral arteries,1.0,90341,-2.60 <= Occlusion of cerebral arteries < 0.04,0.08,0.21,2
eye,C0015392,Eye,Eye. The organ of sight constituting a pair of globular organs made up of a three-layered roughly spherical structure specialized for receiving and responding to light.,0,0.603,0.0,0.0,0.0,0.0002,0.0077,-0.008,0.0001,"Non-cancer illness code, self-reported | Array 0__eye",1.0,91394,"Non-cancer illness code, self-reported | Array 0__eye < 0.23",0.13,0.14,2
eye,C0700042,Orbital region,Orbital region. Subdivision of face which has as its direct parts orbital cavity and its content and eyelids.,0,0.602,0.0,0.0,0.0,0.0002,0.0077,-0.008,0.0001,"Non-cancer illness code, self-reported | Array 0__eye",1.0,91394,"Non-cancer illness code, self-reported | Array 0__eye < 0.23",0.13,0.14,2
"Qualifications College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching",C0028677,Discipline of Nursing,"Discipline of Nursing. The field of nursing care concerned with the promotion, maintenance, and restoration of health.",0,0.342,0.0,0.0,0.0,0.0002,0.0646,-0.006,0.0,"Qualifications_College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching",1.0,91343,"Qualifications_College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching < 0.50",0.01,0.01,3
"Qualifications College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching",C0028678,nursing therapy,"nursing therapy. Used with diseases for nursing care and techniques in their management. It includes the nursing role in diagnostic, therapeutic, and preventive procedures.",0,0.214,0.0,0.0,0.0,0.0002,0.0646,-0.006,0.0,"Qualifications_College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching",1.0,91343,"Qualifications_College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching < 0.50",0.01,0.01,2
medication 50 inhaler,C0021461,Inhaler,Inhaler. A device by means of which a medicinal product can be administered by inspiration through the nose or the mouth.,0,0.627,0.0,0.0,0.0,0.0002,0.0135,-0.008,0.0,Treatment/medication code | Array 0__50 inhaler,1.0,91096,Treatment/medication code | Array 0__50 inhaler < 0.19,-0.04,-0.04,2
medication 50 inhaler,C1881212,Inhaler Dosing Unit,Inhaler Dosing Unit. A dosing unit equal to the amount of active ingredient(s) contained in an inhaler.,0,0.604,0.0,0.0,0.0,0.0002,0.0135,-0.008,0.0,Treatment/medication code | Array 0__50 inhaler,1.0,91096,Treatment/medication code | Array 0__50 inhaler < 0.19,-0.04,-0.04,99
medication 50 inhaler,C4319647,Inhaler (unit of presentation),Inhaler (unit of presentation). ,0,0.632,0.0,0.0,0.0,0.0002,0.0135,-0.008,0.0,Treatment/medication code | Array 0__50 inhaler,1.0,91096,Treatment/medication code | Array 0__50 inhaler < 0.19,-0.04,-0.04,99
gastric reflux,C0558176,Gastric reflux finding,Gastric reflux finding. ,0,0.934,0.0,1.0,0.5,0.0002,0.1785,0.004,0.0,"Non-cancer illness code, self-reported | Array 2__gastric reflux",1.12,1116,"Non-cancer illness code, self-reported | Array 2__gastric reflux >= 0.14",0.23,0.23,2
diverticulitis,C0012813,Diverticulitis,Diverticulitis. Inflammation of a DIVERTICULUM or diverticula.,0,0.923,0.0,0.0,0.0,0.0002,0.0011,0.011,0.0,"Non-cancer illness code, self-reported | Array 2__diverticulitis",1.0,91336,"Non-cancer illness code, self-reported | Array 2__diverticulitis < 0.23",0.32,0.32,2
diverticulitis,C0810029,Diverticulosis and Diverticulitis,"Diverticulosis and Diverticulitis. <p>Diverticula are small pouches that bulge outward through the colon, or large intestine. If you have these pouches, you have a condition called diverticulosis. It becomes more common as people age. About half of all people over age 60 have it. Doctors believe the main cause is a low-fiber diet.</p> <p>Most people with diverticulosis don't have symptoms. Sometimes it causes mild cramps, bloating or constipation. Diverticulosis is often found through tests ordered for something else. For example, it is often found during a colonoscopy to screen for cancer. A high-fiber diet and mild pain reliever will often relieve symptoms.</p> <p>If the pouches become inflamed or infected, you have a condition called diverticulitis. The most common symptom is abdominal pain, usually on the left side. You may also have fever, nausea, vomiting, chills, cramping, and constipation. In serious cases, diverticulitis can lead to bleeding, tears, or blockages. Your doctor will do a physical exam and imaging tests to diagnose it. Treatment may include antibiotics, pain relievers, and a liquid diet. A serious case may require a hospital stay or surgery.</p> <p class="""">NIH: National Institute of Diabetes and Digestive and Kidney Diseases</p>",0,0.815,0.0,0.0,0.0,0.0002,0.0011,0.011,0.0,"Non-cancer illness code, self-reported | Array 2__diverticulitis",1.0,91336,"Non-cancer illness code, self-reported | Array 2__diverticulitis < 0.23",0.32,0.32,99
(non-UK origin) Country of Birth united kingdom,C1300001,Country of birth (finding),Country of birth (finding). ,0,0.7,0.0,0.0,0.0,0.0002,0.1069,-0.005,0.0,(non-UK origin) Country of Birth__united kingdom,1.0,91441,(non-UK origin) Country of Birth__united kingdom < 0.29,0.07,0.07,2
"R29.6 - Tendency to fall, not elsewhere classified",C0085639,Falls,"Falls. A sudden movement downward, usually resulting in injury.",0,0.406,0.0,0.0,0.0,0.0002,0.061,0.005,0.0,"R29.6 - Tendency to fall, not elsewhere classified",1.0,90644,"-6.10 <= R29.6 - Tendency to fall, not elsewhere classified < 0.75",0.03,0.03,2
emphysema,C0013990,Pathological accumulation of air in tissues,Pathological accumulation of air in tissues. A pathological accumulation of air in tissues or organs.,0,0.707,0.0,0.0,0.0,0.0002,0.1014,-0.006,0.0,"Non-cancer illness code, self-reported | Array 0__emphysema",1.0,90854,"Non-cancer illness code, self-reported | Array 0__emphysema < 0.23",0.19,0.31,2
emphysema,C0034067,Pulmonary Emphysema,Pulmonary Emphysema. Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions.,0,0.779,0.0,0.0,0.0,0.0002,0.1014,-0.006,0.0,"Non-cancer illness code, self-reported | Array 0__emphysema",1.0,90854,"Non-cancer illness code, self-reported | Array 0__emphysema < 0.23",0.19,0.31,2
stroke,C0038454,Cerebrovascular accident,"Cerebrovascular accident. A group of pathological conditions characterized by sudden, non-convulsive loss of neurological function due to BRAIN ISCHEMIA or INTRACRANIAL HEMORRHAGES. Stroke is classified by the type of tissue NECROSIS, such as the anatomic location, vasculature involved, etiology, age of the affected individual, and hemorrhagic vs. non-hemorrhagic nature. (From Adams et al., Principles of Neurology, 6th ed, pp777-810)",0,0.614,0.0,0.0,0.0,0.0002,0.0,0.024,0.0002,"Non-cancer illness code, self-reported | Array 0__stroke",1.54,1597,"Non-cancer illness code, self-reported | Array 0__stroke >= 0.50",0.04,0.12,2
Myocardial infarction,C0027051,Myocardial Infarction,Myocardial Infarction. NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).,0,0.756,0.0,0.0,0.0,0.0002,0.0104,-0.004,0.0009,Myocardial infarction,1.24,1129,-4.10 <= Myocardial infarction < -0.88,0.1,0.1,2
Myocardial infarction,C0155668,Old myocardial infarction,"Old myocardial infarction. Documented history of previous myocardial infarction (MI), typically with objective evidence via positive biomarkers of myocardial necrosis.",0,0.713,0.0,0.0,0.0,0.0002,0.0104,-0.004,0.0009,Myocardial infarction,1.24,1129,-4.10 <= Myocardial infarction < -0.88,0.1,0.1,2
Qualifications College or University degree|NVQ or HND or HNC or equivalent,C0205163,Equal,Equal. A person or thing equal to another in value or measure or force or effect or significance etc.; being essentially equal to something.,0,0.263,0.0,0.0,0.0,0.0002,0.1311,0.005,0.0,Qualifications_College or University degree|NVQ or HND or HNC or equivalent,1.0,91315,Qualifications_College or University degree|NVQ or HND or HNC or equivalent < 0.50,-0.08,-0.08,99
embolism,C0013922,Embolism,Embolism. Blocking of a blood vessel by an embolus which can be a blood clot or other undissolved material in the blood stream.,0,0.808,0.0,0.0,0.0,0.0002,0.0,0.026,0.0003,"Non-cancer illness code, self-reported | Array 2__embolism",1.0,91326,"Non-cancer illness code, self-reported | Array 2__embolism < 0.23",0.16,0.16,2
embolism,C1704212,Embolus,"Embolus. A mass of clotted blood or other formed elements, such as bubbles of air, calcium fragments, etc. brought by the blood from another vessel and forced into a smaller one, thus obstructing the circulation.",0,0.72,0.0,0.0,0.0,0.0002,0.0,0.026,0.0003,"Non-cancer illness code, self-reported | Array 2__embolism",1.0,91326,"Non-cancer illness code, self-reported | Array 2__embolism < 0.23",0.16,0.16,2
medication 2mg tablet,C0039225,Tablet Dosage Form,"Tablet Dosage Form. Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed)",0,0.331,0.0,0.0,0.0,0.0002,0.0282,0.007,0.0,Treatment/medication code | Array 0__2mg tablet,1.0,91430,Treatment/medication code | Array 0__2mg tablet < 0.46,0.02,0.02,2
medication 2mg tablet,C1705223,Tablet Dosing Unit,Tablet Dosing Unit. A dosing unit equal to the amount of active ingredient(s) contained in a tablet.,0,0.364,0.0,0.0,0.0,0.0002,0.0282,0.007,0.0,Treatment/medication code | Array 0__2mg tablet,1.0,91430,Treatment/medication code | Array 0__2mg tablet < 0.46,0.02,0.02,99
medication 2mg tablet,C4319774,Tablet (unit of presentation),Tablet (unit of presentation). ,0,0.308,0.0,0.0,0.0,0.0002,0.0282,0.007,0.0,Treatment/medication code | Array 0__2mg tablet,1.0,91430,Treatment/medication code | Array 0__2mg tablet < 0.46,0.02,0.02,99
"Medication for cholesterol, blood pressure or diabetes Medication Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0019,0.0,0.055,0.0014,"Medication for cholesterol, blood pressure or diabetes Medication_Blood pressure medication",1.49,9276,"Medication for cholesterol, blood pressure or diabetes Medication_Blood pressure medication >= 0.50",0.23,0.24,2
Mental health conditions ever diagnosed by a professional group,,,,0,1.0,0.0,0.0,0.0,0.0182,0.0,-0.038,0.0022,Mental health conditions ever diagnosed by a professional__group,1.07,66419,Mental health conditions ever diagnosed by a professional__group < 0.01,0.08,0.08,2
medication arcoxia,,,,0,1.0,0.0,0.0,0.0,0.0006,0.0,0.016,0.0001,Treatment/medication code | Array 0__arcoxia,1.0,91515,Treatment/medication code | Array 0__arcoxia < 0.24,0.12,0.12,2
Home area population density - urban or rural Scotland - Large Urban Area,,,,0,1.0,0.0,0.0,0.0,0.0779,0.0,-0.052,0.0018,Home area population density - urban or rural_Scotland - Large Urban Area,1.04,87079,Home area population density - urban or rural_Scotland - Large Urban Area < 0.50,-0.08,-0.08,2
Qualifications College or University degree|NVQ or HND or HNC or equivalent,,,,0,1.0,0.0,0.0,0.0,0.0002,0.1311,0.005,0.0,Qualifications_College or University degree|NVQ or HND or HNC or equivalent,1.0,91315,Qualifications_College or University degree|NVQ or HND or HNC or equivalent < 0.50,-0.08,-0.08,2
Concentration of Large LDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,-0.024,0.0683,Concentration of Large LDL Particles,1.16,7437,-3.50 <= Concentration of Large LDL Particles < -0.85,0.04,0.19,2
Triglycerides Blood biochemistry,,,,0,1.0,0.0,0.0,0.0,0.014,0.0,0.084,0.0394,Triglycerides Blood biochemistry,1.92,2452,Triglycerides Blood biochemistry >= 2.50,0.16,0.16,2
medication atenolol,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,0.015,0.0001,Treatment/medication code | Array 0__atenolol,1.32,1774,Treatment/medication code | Array 0__atenolol >= 0.19,0.02,0.02,2
medication tablet,,,,0,1.0,0.0,0.0,0.0,0.0056,0.001,-0.008,0.001,Treatment/medication code | Array 0__tablet,1.06,2375,0.26 <= Treatment/medication code | Array 0__tablet < 0.41,0.14,0.14,2
Complications of transplants and reattached limbs,,,,0,1.0,0.0,0.0,0.0,0.0004,0.1044,-0.002,0.0002,Complications of transplants and reattached limbs,0.99,89350,-1.40 <= Complications of transplants and reattached limbs < 0.39,0.15,0.17,2
Concentration of Small LDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0,-0.017,0.0486,Concentration of Small LDL Particles,1.0,80534,-2.80 <= Concentration of Small LDL Particles < 0.19,0.03,0.15,2
Age angina diagnosed,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0001,0.013,0.0001,Age angina diagnosed_35,1.0,91558,Age angina diagnosed_35 < 0.50,0.12,0.12,2
Job code at visit maintenance fitters,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0254,0.007,0.0,Job code at visit__maintenance fitters,1.0,90780,Job code at visit__maintenance fitters < 0.18,-0.01,-0.01,2
"Long-standing illness, disability or infirmity",,,,0,1.0,0.0,0.0,0.0,0.0439,0.0,-0.087,0.0038,"Long-standing illness, disability or infirmity_No",1.28,42073,"Long-standing illness, disability or infirmity_No < 0.50",0.14,0.14,2
renal kidney,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0,0.03,0.0003,"Non-cancer illness code, self-reported | Array 1__renal kidney",1.0,91417,"Non-cancer illness code, self-reported | Array 1__renal kidney < 0.25",0.22,0.22,2
Cholesterol in Small VLDL,,,,0,1.0,0.0,0.0,0.0,0.0008,0.001,-0.012,0.0544,Cholesterol in Small VLDL,1.0,81085,-3.70 <= Cholesterol in Small VLDL < 0.00,0.18,0.18,2
Job code at visit officers,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0166,-0.009,0.0001,Job code at visit__officers,1.01,88472,Job code at visit__officers < 0.09,-0.01,0.0,2
Qualifications College or University degree,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0126,-0.008,0.0,Qualifications_College or University degree,1.01,82420,Qualifications_College or University degree < 0.50,-0.0,0.03,2
"R29.6 - Tendency to fall, not elsewhere classified",,,,0,1.0,0.0,0.0,0.0,0.0002,0.061,0.005,0.0,"R29.6 - Tendency to fall, not elsewhere classified",1.0,90644,"-6.10 <= R29.6 - Tendency to fall, not elsewhere classified < 0.75",0.03,0.03,2
"Medication for cholesterol, blood pressure or diabetes Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0008,0.0,0.055,0.0014,"Medication for cholesterol, blood pressure or diabetes_Blood pressure medication",1.49,9276,"Medication for cholesterol, blood pressure or diabetes_Blood pressure medication >= 0.50",0.24,0.25,2
Qualifications College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,,,,0,1.0,0.0,0.0,0.0,0.0003,0.084,-0.006,0.0,Qualifications_College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent,1.0,91267,Qualifications_College or University degree|O levels/GCSEs or equivalent|NVQ or HND or HNC or equivalent < 0.50,-0.08,-0.08,2
"dietary changes in the last 5 years Yes, because of other reasons",,,,0,1.0,0.0,0.0,0.0,0.0017,0.0065,-0.009,0.0,"Major dietary changes in the last 5 years_Yes, because of other reasons",1.02,67117,"Major dietary changes in the last 5 years_Yes, because of other reasons < 0.50",0.17,0.17,2
"I48.9 - Atrial fibrillation and atrial flutter, unspecified",,,,0,1.0,0.0,0.0,0.0,0.0054,0.4092,0.008,0.0004,"I48.9 - Atrial fibrillation and atrial flutter, unspecified",0.99,89925,"-2.70 <= I48.9 - Atrial fibrillation and atrial flutter, unspecified < 1.10",-0.02,0.15,2
Home area population density - urban or rural Scotland - Accessible Rural,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0003,-0.012,0.0001,Home area population density - urban or rural_Scotland - Accessible Rural,1.0,91322,Home area population density - urban or rural_Scotland - Accessible Rural < 0.50,-0.1,-0.1,2
Mental health conditions ever diagnosed by a professional group depression,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,-0.015,0.001,Mental health conditions ever diagnosed by a professional__group depression,1.01,87484,Mental health conditions ever diagnosed by a professional__group depression < 0.15,-0.01,-0.01,2
Pulse wave reflection index,,,,0,1.0,0.0,0.0,0.0,0.0054,0.6607,-0.001,0.0009,Pulse wave reflection index,1.07,4830,-2.20 <= Pulse wave reflection index < -0.67,-0.1,-0.1,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication|Insulin",,,,0,1.0,0.0,0.0,0.0,0.0004,0.0237,0.007,0.0,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication|Insulin",1.21,1006,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication|Insulin >= 0.50",0.17,0.17,2
Meat substitutes - vegetarian,,,,0,1.0,0.0,0.0,0.0,0.0028,0.255,0.004,0.0001,Meat substitutes - vegetarian,1.01,80042,-0.18 <= Meat substitutes - vegetarian < 3.10,-0.02,-0.02,2
Alcohol intake frequency. Once or twice a week,,,,0,1.0,0.0,0.0,0.0,0.0022,0.0,-0.025,0.0003,Alcohol intake frequency._Once or twice a week,1.04,68558,Alcohol intake frequency._Once or twice a week < 0.50,0.02,0.11,2
Vascular/heart problems diagnosed by doctor None of the above,,,,0,1.0,0.0,0.0,0.0,0.0425,0.0,-0.115,0.0066,Vascular/heart problems diagnosed by doctor_None of the above,1.38,41874,Vascular/heart problems diagnosed by doctor_None of the above < 0.50,0.05,0.05,2
Overall health rating Good,,,,0,1.0,0.0,0.0,0.0,0.0095,0.0,-0.048,0.0012,Overall health rating_Good,1.15,43190,Overall health rating_Good < 0.50,-0.01,-0.01,2
Job code at visit assistants,,,,0,1.0,0.0,0.0,0.0,0.0026,0.016,-0.009,0.0001,Job code at visit__assistants,1.01,87221,Job code at visit__assistants < 0.11,-0.02,-0.02,2
Apolipoprotein B Blood biochemistry,,,,0,1.0,0.0,0.0,0.0,0.0393,0.0,-0.036,0.0098,Apolipoprotein B Blood biochemistry,1.43,1791,-1.60 <= Apolipoprotein B Blood biochemistry < -1.50,0.2,0.22,2
Home area population density - urban or rural Scotland - Accessible Small Town,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0288,-0.007,0.0,Home area population density - urban or rural_Scotland - Accessible Small Town,1.0,91323,Home area population density - urban or rural_Scotland - Accessible Small Town < 0.50,-0.12,-0.12,2
Average Diameter for HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0,-0.021,0.03,Average Diameter for HDL Particles,1.15,7281,-3.00 <= Average Diameter for HDL Particles < -0.96,0.05,0.06,2
"Complications of cardiac/vascular device, implant, and graft",,,,0,1.0,0.0,0.0,0.0,0.0002,0.0207,-0.005,0.0006,"Complications of cardiac/vascular device, implant, and graft",0.99,90391,"-0.28 <= Complications of cardiac/vascular device, implant, and graft < 0.01",0.11,0.11,2
Vascular/heart problems diagnosed by doctor High blood pressure,,,,0,1.0,0.0,0.0,0.0,0.0017,0.0,0.082,0.0032,Vascular/heart problems diagnosed by doctor_High blood pressure,1.34,30845,Vascular/heart problems diagnosed by doctor_High blood pressure >= 0.50,0.07,0.07,2
Job code at visit professionals,,,,0,1.0,0.0,0.0,0.0,0.001,0.0,-0.022,0.0004,Job code at visit__professionals,1.02,85437,Job code at visit__professionals < 0.11,-0.05,-0.05,2
dietary changes in the last 5 years,,,,0,1.0,0.0,0.0,0.0,0.0066,0.0,-0.033,0.0005,Major dietary changes in the last 5 years_No,1.11,39187,Major dietary changes in the last 5 years_No < 0.50,0.09,0.09,2
Fluid intelligence score,,,,0,1.0,0.0,0.0,0.0,0.0011,0.0108,-0.008,0.0001,Fluid intelligence score,1.26,1102,-3.60 <= Fluid intelligence score < -2.80,-0.01,-0.01,2
W19.9 - Unspecified place,,,,0,1.0,0.0,0.0,0.0,0.0011,0.4607,-0.002,0.0001,W19.9 - Unspecified place,1.0,90852,-7.00 <= W19.9 - Unspecified place < 0.04,-0.02,-0.02,2
"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones Cholesterol lowering medication|Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0016,0.0,0.03,0.0004,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Cholesterol lowering medication|Blood pressure medication",1.5,2844,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Cholesterol lowering medication|Blood pressure medication >= 0.50",0.15,0.15,2
Cholesterol in Small HDL,,,,0,1.0,0.0,0.0,0.0,0.0018,0.0,0.009,0.0561,Cholesterol in Small HDL,1.24,2916,1.90 <= Cholesterol in Small HDL < 4.00,0.2,0.2,2
Circulatory disease NEC,,,,0,1.0,0.0,0.0,0.0,0.0013,0.039,-0.002,0.0007,Circulatory disease NEC,1.39,1979,-4.80 <= Circulatory disease NEC < -0.20,0.1,0.1,2
Age angina diagnosed infrequent,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0,0.021,0.0002,Age angina diagnosed_infrequent_,1.0,91445,Age angina diagnosed_infrequent_ < 0.50,0.05,0.05,2
medication adalat 5mg,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,0.014,0.0001,Treatment/medication code | Array 0__adalat 5mg,1.0,91198,Treatment/medication code | Array 0__adalat 5mg < 0.24,-0.04,-0.04,2
Age diabetes diagnosed,,,,0,1.0,0.0,0.0,0.0,0.0039,0.0,0.027,0.0012,Age diabetes diagnosed,1.52,1339,Age diabetes diagnosed >= 2.50,0.14,0.19,2
Home area population density - urban or rural England/Wales - Urban - less sparse,,,,0,1.0,0.0,0.0,0.0,0.005,0.0,0.034,0.0006,Home area population density - urban or rural_England/Wales - Urban - less sparse,1.05,73086,Home area population density - urban or rural_England/Wales - Urban - less sparse >= 0.50,-0.03,-0.03,2
M54.56 - Low back pain (Lumbar region),,,,0,1.0,0.0,0.0,0.0,0.0013,0.0004,0.012,0.0002,M54.56 - Low back pain (Lumbar region),1.0,91086,-17.00 <= M54.56 - Low back pain (Lumbar region) < 0.75,0.05,0.05,2
M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,,,,0,1.0,0.0,0.0,0.0,0.0006,0.0877,0.007,0.0002,M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy,1.0,90946,-9.00 <= M51.1 - Lumbar and other intervertebral disk disorders with radiculopathy < 4.40,0.17,0.18,2
Job code at visit transport,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0765,0.006,0.0,Job code at visit__transport,1.0,91097,Job code at visit__transport < 0.22,-0.05,-0.05,2
dietary changes in the last 5 years Prefer not to answer,,,,0,1.0,0.0,0.0,0.0,0.0003,0.013,0.008,0.0,Major dietary changes in the last 5 years_Prefer not to answer,1.0,91330,Major dietary changes in the last 5 years_Prefer not to answer < 0.50,0.06,0.06,2
Concentration of VLDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0074,0.004,0.0524,Concentration of VLDL Particles,1.22,962,3.60 <= Concentration of VLDL Particles < 6.20,-0.05,0.05,2
M47.82 - Other spondylosis (Cervical region),,,,0,1.0,0.0,0.0,0.0,0.0011,0.1002,-0.005,0.0002,M47.82 - Other spondylosis (Cervical region),1.0,90852,-0.73 <= M47.82 - Other spondylosis (Cervical region) < 0.34,0.18,0.19,2
Home area population density - urban or rural Scotland - Other Urban Area,,,,0,1.0,0.0,0.0,0.0,0.0136,0.0,-0.027,0.0005,Home area population density - urban or rural_Scotland - Other Urban Area,1.01,90570,Home area population density - urban or rural_Scotland - Other Urban Area < 0.50,-0.0,0.01,2
Apolipoprotein A Blood biochemistry,,,,0,1.0,0.0,0.0,0.0,0.048,0.0127,-0.012,0.0102,Apolipoprotein A Blood biochemistry,1.15,7980,-2.10 <= Apolipoprotein A Blood biochemistry < -1.20,0.17,0.17,2
Z92.1 - Personal history of long-term (current) use of anticoagulants,,,,0,1.0,0.0,0.0,0.0,0.0149,0.0112,0.001,0.0017,Z92.1 - Personal history of long-term (current) use of anticoagulants,1.66,2685,Z92.1 - Personal history of long-term (current) use of anticoagulants >= 1.30,0.04,0.04,2
Arm fat percentage,,,,0,1.0,0.0,0.0,0.0,0.0405,0.2027,0.016,0.0041,Arm fat percentage (left),1.18,16282,-0.01 <= Arm fat percentage (left) < 0.61,0.07,0.07,2
Cholesterol in IDL,,,,0,1.0,0.0,0.0,0.0,0.0021,0.0,-0.038,0.0679,Cholesterol in IDL,1.76,1026,-4.60 <= Cholesterol in IDL < -3.20,0.29,0.29,2
medication 5mg capsule,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0,0.014,0.0001,Treatment/medication code | Array 0__5mg capsule,1.0,91198,Treatment/medication code | Array 0__5mg capsule < 0.41,-0.09,-0.09,2
Average Diameter for VLDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0011,0.0,0.031,0.0285,Average Diameter for VLDL Particles,1.87,986,3.30 <= Average Diameter for VLDL Particles < 5.90,-0.02,0.02,2
Other serious medical condition/disability diagnosed by doctor,,,,0,1.0,0.0,0.0,0.0,0.0013,0.0,-0.062,0.0018,Other serious medical condition/disability diagnosed by doctor_No,1.3,25187,Other serious medical condition/disability diagnosed by doctor_No < 0.50,0.18,0.18,2
Z87.4 - Personal history of diseases of the genito-urinary system,,,,0,1.0,0.0,0.0,0.0,0.0012,0.7627,0.003,0.0002,Z87.4 - Personal history of diseases of the genito-urinary system,0.99,89488,-2.00 <= Z87.4 - Personal history of diseases of the genito-urinary system < 0.02,0.04,0.04,2
Average Diameter for LDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0,-0.027,0.0039,Average Diameter for LDL Particles,1.21,7036,-5.50 <= Average Diameter for LDL Particles < -0.75,0.01,0.11,2
Job code at visit working production,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0254,0.007,0.0,Job code at visit__working production,1.0,90780,Job code at visit__working production < 0.18,-0.07,-0.07,2
"Qualifications College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching",,,,0,1.0,0.0,0.0,0.0,0.0002,0.0646,-0.006,0.0,"Qualifications_College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching",1.0,91343,"Qualifications_College or University degree|A levels/AS levels or equivalent|Other professional qualifications eg: nursing, teaching < 0.50",0.01,0.01,2
"Medication for cholesterol, blood pressure or diabetes Cholesterol lowering medication|Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0006,0.0,0.085,0.0032,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication",1.58,14743,"Medication for cholesterol, blood pressure or diabetes_Cholesterol lowering medication|Blood pressure medication >= 0.50",0.18,0.18,2
Y83.6 - Removal of other organ (partial) (total),,,,0,1.0,0.0,0.0,0.0,0.0002,0.0694,-0.006,0.0002,Y83.6 - Removal of other organ (partial) (total),1.0,90691,-6.50 <= Y83.6 - Removal of other organ (partial) (total) < 3.20,0.12,0.12,2
Townsend deprivation index at recruitment,,,,0,1.0,0.0,0.0,0.0,0.0097,0.0,0.025,0.0094,Townsend deprivation index at recruitment,1.19,10276,1.40 <= Townsend deprivation index at recruitment < 2.90,-0.02,-0.02,2
Z96.6 - Presence of orthopaedic joint implants,,,,0,1.0,0.0,0.0,0.0,0.0008,0.0006,-0.007,0.0003,Z96.6 - Presence of orthopaedic joint implants,1.33,1458,-6.30 <= Z96.6 - Presence of orthopaedic joint implants < -0.35,0.09,0.2,2
Number of treatments/medications taken,,,,0,1.0,0.0,0.0,0.0,0.0808,0.0,0.136,0.01,Number of treatments/medications taken,2.16,4076,Number of treatments/medications taken >= 2.00,-0.1,-0.1,2
Job code at visit electronics,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0049,-0.009,0.0,Job code at visit__electronics,1.0,91117,Job code at visit__electronics < 0.24,-0.04,0.0,2
Number of self-reported non-cancer illnesses,,,,0,1.0,0.0,0.0,0.0,0.088,0.0,0.138,0.0101,Number of self-reported non-cancer illnesses,2.36,1149,Number of self-reported non-cancer illnesses >= 3.00,0.02,0.02,2
Job code at visit engineers,,,,0,1.0,0.0,0.0,0.0,0.0005,0.0005,-0.012,0.0001,Job code at visit__engineers,1.01,88634,Job code at visit__engineers < 0.12,-0.02,0.01,2
M25.56 - Pain in joint (Lower leg),,,,0,1.0,0.0,0.0,0.0,0.001,0.0548,0.008,0.0003,M25.56 - Pain in joint (Lower leg),0.99,90802,-0.65 <= M25.56 - Pain in joint (Lower leg) < 0.29,0.02,0.02,2
Job code at visit chartered,,,,0,1.0,0.0,0.0,0.0,0.001,0.0684,-0.006,0.0,Job code at visit__chartered,1.0,90183,Job code at visit__chartered < 0.14,-0.03,-0.03,2
Z03.8 - Observation for other suspected diseases and conditions,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0591,0.004,0.0002,Z03.8 - Observation for other suspected diseases and conditions,1.0,89673,-0.22 <= Z03.8 - Observation for other suspected diseases and conditions < 0.38,0.14,0.14,2
Vascular/heart problems diagnosed by doctor Heart attack|High blood pressure,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0,0.027,0.0003,Vascular/heart problems diagnosed by doctor_Heart attack|High blood pressure,1.7,1171,Vascular/heart problems diagnosed by doctor_Heart attack|High blood pressure >= 0.50,0.11,0.11,2
Peripheral enthesopathies and allied syndromes,,,,0,1.0,0.0,0.0,0.0,0.0009,0.1883,0.006,0.0004,Peripheral enthesopathies and allied syndromes,0.99,89222,-2.10 <= Peripheral enthesopathies and allied syndromes < 0.90,0.16,0.21,2
Concentration of Medium HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0005,0.0026,0.004,0.06,Concentration of Medium HDL Particles,1.18,1085,3.70 <= Concentration of Medium HDL Particles < 8.70,0.05,0.09,2
"M15.9 - Polyarthrosis, unspecified",,,,0,1.0,0.0,0.0,0.0,0.0039,0.0127,0.01,0.0002,"M15.9 - Polyarthrosis, unspecified",0.99,90102,"-0.16 <= M15.9 - Polyarthrosis, unspecified < 0.86",0.2,0.2,2
Z51.5 - Palliative care,,,,0,1.0,0.0,0.0,0.0,0.0244,0.7013,-0.004,0.0013,Z51.5 - Palliative care,1.02,90035,-0.46 <= Z51.5 - Palliative care < 0.85,-0.0,-0.0,2
Qualifications NVQ or HND or HNC or equivalent,,,,0,1.0,0.0,0.0,0.0,0.0003,0.0026,0.01,0.0,Qualifications_NVQ or HND or HNC or equivalent,1.1,7423,Qualifications_NVQ or HND or HNC or equivalent >= 0.50,-0.07,-0.07,2
Overall health rating Fair,,,,0,1.0,0.0,0.0,0.0,0.001,0.0,0.05,0.0012,Overall health rating_Fair,1.24,25623,Overall health rating_Fair >= 0.50,-0.02,-0.02,2
"dietary changes in the last 5 years Yes, because of illness",,,,0,1.0,0.0,0.0,0.0,0.0012,0.0,0.054,0.0013,"Major dietary changes in the last 5 years_Yes, because of illness",1.37,14262,"Major dietary changes in the last 5 years_Yes, because of illness >= 0.50",0.13,0.13,2
Home area population density - urban or rural England/Wales - Town and Fringe - less sparse,,,,0,1.0,0.0,0.0,0.0,0.0024,0.0067,0.009,0.0,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse,1.1,5915,Home area population density - urban or rural_England/Wales - Town and Fringe - less sparse >= 0.50,-0.04,-0.04,2
Other ill-defined and unknown causes of morbidity and mortality,,,,0,1.0,0.0,0.0,0.0,0.0029,0.7584,-0.005,0.0005,Other ill-defined and unknown causes of morbidity and mortality,1.46,1258,Other ill-defined and unknown causes of morbidity and mortality >= 3.00,0.25,0.25,2
Alcohol intake frequency. Three or four times a week,,,,0,1.0,0.0,0.0,0.0,0.0019,0.0042,0.009,0.0,Alcohol intake frequency._Three or four times a week,1.05,21264,Alcohol intake frequency._Three or four times a week >= 0.50,0.02,0.09,2
Concentration of HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0013,0.1116,0.002,0.0387,Concentration of HDL Particles,1.21,2381,Concentration of HDL Particles < -2.30,0.07,0.12,2
Overall health rating Excellent,,,,0,1.0,0.0,0.0,0.0,0.0065,0.0,-0.046,0.0012,Overall health rating_Excellent,1.05,81543,Overall health rating_Excellent < 0.50,-0.02,-0.02,2
medication cilexetil,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0972,0.005,0.0,Treatment/medication code | Array 0__cilexetil,1.0,91269,Treatment/medication code | Array 0__cilexetil < 0.29,0.1,0.1,2
Cancer of prostate,,,,0,1.0,0.0,0.0,0.0,0.0022,0.7964,0.0,0.0003,Cancer of prostate,1.01,88093,-0.14 <= Cancer of prostate < 0.15,0.09,0.09,2
medication diclofenac,,,,0,1.0,0.0,0.0,0.0,0.0028,0.0,0.015,0.0001,Treatment/medication code | Array 0__diclofenac,1.0,90740,Treatment/medication code | Array 0__diclofenac < 0.37,0.1,0.1,2
medication capsule,,,,0,1.0,0.0,0.0,0.0,0.0004,0.0,-0.014,0.0007,Treatment/medication code | Array 0__capsule,1.01,88303,Treatment/medication code | Array 0__capsule < 0.24,0.06,0.06,2
(HDL) high density lipoprotein cholesterol genetic risk,,,,0,1.0,0.0,0.0,0.0,0.0129,0.0,-0.021,0.307,(HDL) high density lipoprotein cholesterol genetic risk,1.15,7182,(HDL) high density lipoprotein cholesterol genetic risk < -1.40,0.21,0.21,2
medication 2mg tablet,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0282,0.007,0.0,Treatment/medication code | Array 0__2mg tablet,1.0,91430,Treatment/medication code | Array 0__2mg tablet < 0.46,0.02,0.02,2
Y83.8 - Other surgical procedures,,,,0,1.0,0.0,0.0,0.0,0.0008,0.0399,0.008,0.0002,Y83.8 - Other surgical procedures,0.99,89841,-2.00 <= Y83.8 - Other surgical procedures < 0.00,0.14,0.14,2
Z53.8 - Procedure not carried out for other reasons,,,,0,1.0,0.0,0.0,0.0,0.0057,0.1478,-0.006,0.0003,Z53.8 - Procedure not carried out for other reasons,1.47,1325,-5.30 <= Z53.8 - Procedure not carried out for other reasons < -0.68,-0.05,-0.05,2
Concentration of Large HDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0008,0.0,-0.025,0.0679,Concentration of Large HDL Particles,1.47,954,-3.10 <= Concentration of Large HDL Particles < -2.30,0.07,0.15,2
Qualifications College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0001,-0.013,0.0001,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent,1.01,88450,Qualifications_College or University degree|A levels/AS levels or equivalent|O levels/GCSEs or equivalent < 0.50,0.04,0.04,2
"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones Blood pressure medication",,,,0,1.0,0.0,0.0,0.0,0.0018,0.0,0.014,0.0001,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Blood pressure medication",1.23,3018,"Medication for cholesterol, blood pressure, diabetes, or take exogenous hormones_Blood pressure medication >= 0.50",0.2,0.2,2
medication alfacalcidol,,,,0,1.0,0.0,0.0,0.0,0.0009,0.0,0.038,0.0004,Treatment/medication code | Array 0__alfacalcidol,1.0,91465,Treatment/medication code | Array 0__alfacalcidol < 0.50,0.21,0.21,2
"N18.3 - Chronic kidney disease, stage",,,,0,1.0,0.0,0.0,0.0,0.0083,0.1787,0.012,0.0011,"N18.3 - Chronic kidney disease, stage 3",0.98,90180,"-0.83 <= N18.3 - Chronic kidney disease, stage 3 < 1.20",0.04,0.04,2
Overall health rating Poor,,,,0,1.0,0.0,0.0,0.0,0.0033,0.0,0.056,0.0014,Overall health rating_Poor,1.6,6756,Overall health rating_Poor >= 0.50,-0.05,-0.05,2
Alcohol intake frequency. One to three times a month,,,,0,1.0,0.0,0.0,0.0,0.0013,0.0,-0.028,0.0004,Alcohol intake frequency._One to three times a month,1.03,82577,Alcohol intake frequency._One to three times a month < 0.50,0.02,0.09,2
Hip circumference,,,,0,1.0,0.0,0.0,0.0,0.0957,0.0,0.022,0.0023,Hip circumference,1.21,1302,2.80 <= Hip circumference < 4.50,-0.08,-0.08,2
Concentration of IDL Particles,,,,0,1.0,0.0,0.0,0.0,0.0022,0.0,-0.033,0.0604,Concentration of IDL Particles,1.43,2252,-3.80 <= Concentration of IDL Particles < -2.40,0.01,0.09,2
medication glucosamine product,,,,0,1.0,0.0,0.0,0.0,0.0002,0.0,-0.015,0.0001,Treatment/medication code | Array 0__glucosamine product,1.0,90546,Treatment/medication code | Array 0__glucosamine product < 0.30,0.1,0.1,2
